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Despite	 maximal	 treatment	 with	 surgical	 resection,	 radiotherapy	 and	 temozolomide	
chemotherapy,	prognosis	is	dismal	with	median	survival	around	15	months.	GBMs	are	highly	






hard	 to	define	with	 tumor	progression.	Although	T2-weighted	and	 contrast-enhanced	T1-
weighted	MRI	provides	anatomical	details	of	the	tumor	architecture,	these	methods	can	be	
confounded	by	pseudoprogression	and	pseudoresponse	in	the	context	of	therapy.	
The	 GBM	 microenvironment	 is	 characterized	 by	 immature	 vasculature	 and	
extracellular	 acidification	 due	 to	 a	 metabolic	 shift	 towards	 aerobic	 glycolysis	 (Warburg	
effect).	The	reduced	extracellular	pH	(pHe)	has	been	associated	with	promoting	angiogenesis	
and	invasion	as	well	as	creating	an	immunosuppressive	environment.	Given	the	important	






spectroscopic	 imaging	 (MRSI)	 technique	 that	utilizes	 the	 temperature	and	pH-dependent	
hyperfine	 shifts	 of	 paramagnetic	 agents	 (e.g.,	 TmDOTP5-)	 for	 high	 resolution,	 three-
dimensional,	 quantitative	 temperature	 and	 pHe	 mapping.	 BIRDS	 has	 been	 used	 to	
demonstrate	 the	acidic	pH	 in	preclinical	models	of	GBM,	where	 the	 intratumoral	space	 is	
highly	 acidified	 (pH<6.8)	 in	 comparison	 to	 healthy	 brain	 tissue	 (pH~7.2)	 and	 acidic	 pH	







Since	 other	 tomographic	 pHe	 mapping	methods	 are	 non-quantitative	 and	 directly	
altering	pHe	in	a	specific	tissue	is	difficult	to	implement,	we	looked	to	assess	the	ability	of	
BIRDS-based	temperature	measurements	to	evaluate	a	localized	cooling	system	that	induces	
hypothermia	 in	 sheep	 brain	 to	 levels	 suggested	 to	 be	 neuroprotective	 in	 hypoxic	 states.	
Quantitative	 temperature	mapping	 using	 BIRDS	 showed	 significantly	 decreased	 cerebral	





contrast	 enhanced	 (DCE)	 MRI,	 which	 allows	 quantification	 of	 vascular	 parameters	 (e.g.,	
permeability)	 through	 modeling	 the	 dynamic	 uptake	 of	 Gd3+-based	 contrast	 agents.	
Multiparametric	 characterization	of	 the	 spatiotemporal	 changes	 in	 cellularity,	 vascularity	
and	acidosis	of	U87	and	U251	tumors	throughout	progression	showed	unique	patterns	that	
could	be	used	to	identify	tumor	features	and	differentiate	between	tumor	types.		
	 Finally,	pHe	 readouts	have	potential	 as	a	biomarker	of	 therapeutic	 response.	After	
finding	 an	 increase	 in	 pHe	 after	 treatment	with	 temozolomide	 in	 U251	 tumors,	we	 used	
BIRDS	 longitudinally	 to	 demonstrate	 normalization	 of	 pHe	 in	 U87	 tumors	 treated	 with	
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GBMs	 exhibit	 unique	 genetic	 and	metabolic	 alterations,	 as	well	 as	 a	 characteristic	 tumor	
microenvironment	that	is	shaped	by	the	properties	of	surrounding	brain	tissue.	Like	other	
solid	 tumors,	 GBMs	 exhibit	 several	 of	 the	 hallmarks	 of	 cancer	 including	 altered	 cellular	















is	 the	 most	 common	 primary	 central	 nervous	 system	 (CNS)	 tumor	 in	 adults	 with	
approximately	10,000	new	cases	each	year	in	the	United	States.1	GBMs	exhibit	characteristic	
genetic	 and	 metabolic	 alterations	 and,	 like	 other	 solid	 tumors,	 maintain	 a	 tumor	
microenvironment	 that	 favors	 proliferation	 and	 invasion	 into	 surrounding	 tissue.	 Many	
connections	 between	 tumor	metabolism	 and	 the	microenvironment	 have	 been	 explored,	
including	 how	 genetic	 changes	 in	 cellular	 metabolism	 impact	 the	 local	 vasculature	 and	
microenvironment.		
Alterations	 in	 cellular	 metabolism	 are	 a	 hallmark	 of	 cancer.2	 This	 dysregulation	
promotes	a	switch	to	glycolysis	even	in	the	presence	of	oxygen,	termed	aerobic	glycolysis	by	
Otto	Warburg	or	otherwise	known	as	the	Warburg	effect.3	However,	a	clear	link	also	exists	
between	 hypoxia	 and	 acidosis.	With	 this	 switch	 comes	 an	 overproduction	 of	 lactate	 and	
protons	that	first	accumulate	in	the	intracellular	compartment	and	are	then	extruded	from	
the	 cell	 into	 the	 extracellular	 space,	 resulting	 in	 extracellular	 acidosis	 (Figure	 1.1).	 To	
accomplish	this,	cells	upregulate	many	transporters	including	the	proton-sodium	exchanger	
(NHE1)	as	well	as	monocarboxylate	transporters	(MCT4)	to	transport	lactate	out	of	the	cell.4	
The	pH	of	 the	 extracellular	 space	becomes	 significantly	 lower	 than	 that	 found	 in	normal	
tissues.	 Further,	 acidosis	may	be	 regulated	 independently	 to	promote	more	 invasive	 and	
metastatic	 cancers	 as	 well	 as	 driving	 tumor	 growth.5,6	 Extracellular	 acidosis	 results	 in	
remodeling	of	the	extracellular	matrix	and	shaping	the	tumor	microenvironment	as	well	as	









Figure	 1.1.	 Tumor	 cell	 metabolism.	 Blood	 delivers	 both	 glucose	 and	 oxygen	 to	 the	 cell.	
Glucose	 is	 taken	 up	 by	 glucose	 transporters	 (GLUTs).	 Glucose	 then	 enters	 the	 glycolytic	
pathway	where	it	is	converted	to	pyruvate.	Pyruvate	is	then	either	converted	to	lactate	or	
enters	the	oxidative	phosphorylation	pathway.	The	ratio	in	the	rate	of	glycolytic	metabolism	
(CMRglc)	 to	 the	 rate	 of	 oxidative	 phosphorylation	 (CMRO2)	 is	 altered	 in	 tumor	 cells.	 To	
prevent	 acidification	 of	 the	 intracellular	 environment,	 lactate	 is	 extruded	 from	 the	 cell	






Glioblastomas	are	 the	most	prevalent	malignant	CNS	 tumors	 in	adults	and	carry	a	
poor	prognosis.10,11	Gliomas	are	solid	 tumors	 that	 form	 in	 the	brain	parenchyma	and	are	
composed	of	glial	cells	and	astrocytes.	Gliomas	as	a	more	general	class	of	tumors	are	divided	
into	 four	grades,	with	grade	4	being	glioblastoma.	There	 is	no	clear	association	with	risk	
factors	 for	 developing	 CNS	 tumors;	 however,	 the	 general	 characteristics	 of	 the	 patient	







	 Glioblastomas	 are	 initially	 diagnosed	 with	 imaging	 modalities,	 such	 as	 computed	
tomography	(CT)	and	magnetic	resonance	imaging	(MRI).13	However,	due	to	the	infrequency	
of	the	tumors,	screening	is	not	usually	performed.	Therefore,	diagnosis	is	either	incidental,	
or	much	more	 frequently	 only	 after	 the	 onset	 of	 symptoms.	 This	 lack	 of	 early	 detection	
means	that	the	tumors	are	large	enough	(or	affecting	more	critical	brain	structures)	before	
diagnosis	is	made;	tumors	are	often	greater	than	1	cm	in	size.	As	tumors	grow,	they	increase	
intracranial	 pressure	 often	 resulting	 in	 compression	 of	 brain	 tissue	 that	 can	 lead	 to	
neurologic	symptoms.	Official	diagnosis	still	requires	histology,	either	from	biopsy,	or	more	
commonly	at	the	time	of	surgical	resection.14	Further,	glioblastomas	are	highly	aggressive	




	 Treatment	 for	 glioblastoma	 includes	 surgery,	 radiotherapy,	 and	 adjuvant	

















infiltrating	 tumor	cells	 is	currently	an	unmet	diagnostic	 imaging	need.	Following	surgical	
resection	 of	 the	 tumor,	 secondary	 treatments	 include	 radiotherapy.17	 Radiotherapy	 can	
 7 





manipulation	 of	 the	 tumor	microenvironment,	 testing	 different	 chemotherapy	 strategies,	
and	directly	probing	 the	acidity	and	hypoxia	 that	develops	 in	 tumors	 requires	 the	use	of	
preclinical	animal	models	of	GBM.	From	patient	samples,	it	has	been	appreciated	that	many	
tumors	 have	 different	 driving	 mutations,	 morphology,	 and	 metabolic	 profiles,	 making	
predicting	 therapeutic	 efficacy	 and	 forming	 a	 cohesive	 representation	 of	 the	 tumor	
microenvironment	difficult.	Therefore,	preclinical	models	of	GBM	that	recapitulate	human	
GBM	are	needed.		
Preclinical	models	 of	 GBM	have	 focused	 on	 a	 few	 key	 rodent	 cell	 lines	 as	well	 as	
patient-derived	cell	lines,	which	are	used	in	immunosuppressed	rodents.	Rat	glioma	models	
include	the	C6,	9L,	RG2,	and	CNS-1	gliomas	20	and	in	mice,	the	GL-261	glioma	model.	There	
are	 several	 models	 of	 GBM	 in	 rats	 (RG2,	 U87,	 U251)	 that	 have	 been	 used	 for	 in	 vitro	






to	 grow	 in	 immunocompetent	 animals.	 The	 RG2	 tumor	 was	 initially	 generated	 by	 the	
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administration	 of	 ethylnitrosurea	 to	 a	 pregnant	 Fisher	 rat,	 which	 resulted	 in	 tumor	
development	 in	 offspring	 that	 could	 be	 collected	 and	maintained	 in	 vitro.21	 RG2	 tumors	
exhibit	 invasive	 growth	 patterns	 and	 are	 non-immunogenic	 in	 Fisher	 rats.	 In	 terms	 of	
genetics,	RG2	has	wild-type	p53	and	has	increased	expression	of	several	genes	including	Ras,	
cyclin	D2,	 PDGFß,	 IGF-1,	 and	 Erb3/HER3.22	 RG2	 cells	 develop	 reproducible	 solid	 tumors	
when	 injected	 in	 vivo	 and	 develop	 minor	 necrotic	 regions	 independent	 of	 tumor	 size.5	
Minimal	signs	of	inflammation	or	gliosis	outside	of	the	tumor	can	be	identified.	RG2	tumors	
induce	disruption	of	the	blood	brain	barrier	and	produce	edema	surrounding	the	tumor.21	
There	 is	 a	 role	 of	 pericytes	 in	 RG2	 tumors	 for	 promoting	 angiogenesis	 and	 leading	 to	
increased	permeability	of	the	tumor	vasculature.23	Many	metabolic	studies	were	performed	
on	C6	cells.	The	C6	model	has	been	widely	used	because	it	has	similar	genetic	changes	to	
those	 seen	 in	 human	 gliomas;	 however,	 it	 is	 immunogenic	 and	 cannot	 be	 used	 in	
immunocompetent	 rats	 or	 used	 to	 test	 immunotherapy.	 It	 forms	 pleomorphic	 cells	with	
variable	 nuclear	 sizes	 and	 it	 does	 invade	 into	 surrounding	 brain.	 The	 9L	 gliosarcoma	 is	
another	model	used	in	Fisher	rats	and	is	the	most	widely	used	glioma	model.	The	9L	tumor	
is	 immunogenic	 and	 in	 some	 cases	 can	 be	 completely	 eliminated	 by	 robust	 anti-tumor	
immune	 responses.	 However,	 the	 tumors	 formed	 are	 well	 circumscribed	 and	 do	 not	
demonstrate	invasion	into	surrounding	tissue	and	are	not	representation	of	this	property	of	
human	 GBMs.	 Conversely,	 the	 RG2	 glioma	 has	 a	 highly	 infiltrative	 pattern	 of	 growth;	
however,	it	is	not	immunogenic	when	used	in	Fischer	rats	and	therefore	cannot	be	used	to	
study	 immune	response	or	 immunotherapy.	Human	GBMs	are	generally	considered	to	be	
weakly	 immunogenic	 and	 this	 must,	 to	 an	 extent,	 be	 replicated	 in	 rodents	 for	 more	












can	 be	 useful	 for	 studying	 tumor	 characteristics	 such	 as	 invasion,	 angiogenesis,	 or	 the	
therapeutic	 response	 to	 non-immune	 mediated	 therapies.	 Both	 U251	 and	 U87	 are	










morphology	 of	 human	 GBM	 and	 recapitulate	 the	 tumor	 microenvironment.	 Further,	 in	
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immunogenic	models,	the	anti-tumor	immune	responses	have	also	been	able	to	be	studied	
















microenvironment	 in	 promoting	 tumor	 progression.	 Specifically,	 some	 key	 features	
including	 the	presence	of	 tenascin-C,	 fibronectin,	 laminin,	and	collagen	 lead	 to	 tumor	cell	
invasion	into	surrounding	tissue.32	There	also	may	be	a	role	of	cancer	stem	cells	in	promoting	
tumorigenesis	 as	 well	 as	 tumor	 progression.33	 The	 unique	 composition	 of	 the	









cells	 becoming	 located	 farther	 away	 from	 the	 vasculature.	 This	 results	 in	 regions	 of	 the	
tumor	 becoming	 hypoxic.	 However,	 tumor	 cells	 adapt	 to	 this	 changing	 landscape	 by	




both	 pro-	 and	 anti-angiogenic	 factors;	 however,	 of	 primary	 importance	 is	 vascular	
endothelial	 growth	 factor	 (VEGF).	 VEGF	 induces	 both	 angiogenesis	 and	 increases	 the	
vascular	permeability,	resulting	in	leaky	vasculature.	Without	angiogenesis,	tumors	cannot	
grow	beyond	a	critical	size	from	which	these	hypoxic	regions	develop	that	will	ultimately	
lead	 to	 necrosis.37	 Therefore,	 angiogenic	 processes	 are	 necessary	 for	 sustained	 tumor	
growth.	 Given	 that	 the	 vasculature	 is	 present	 outside	 of	 the	 tumor	 and	 this	 is	 where	
angiogenesis	occurs,	blood	vessels	tend	to	be	located	near	the	tumor	periphery,	rather	than	
in	the	tumor	core,	which	is	also	why	necrosis	tends	to	develop	in	deeper	regions	of	tumors.	





which	provide	 a	barrier	 to	nearly	 all	 non-selective	 transport,	 including	both	 endogenous	
molecules	and	exogenous	agents.21	The	endothelial	cells	are	associated	with	astrocytes	and	




This	 abnormal	 vasculature	 results	 in	 an	 increase	 blood	 volume,	 but	 blood	 flow	may	 be	
reduced	 because	 of	 the	 tortuous	 network.	 Even	 regions	 of	 tumors	 that	 exhibit	 high	
vascularity	may	show	a	reduction	in	perfusion	with	perfusion	rates	in	some	tumors	being	
















environments	 requiring	 the	 diffusion	 of	 both	 glucose	 and	 oxygen	 across	 the	 basement	
membrane.	 As	 cancer	 cells	 proliferate	 and	 the	 tumor	 increases	 in	 size,	 the	 necessary	
diffusion	distance	increases	resulting	in	only	the	outermost	cells	receiving	levels	of	nutrients	





The	 glycolytic	 switch	 occurs	 before	 the	 angiogenic	 switch	 as	 lactic	 acid	 increases	
precede	 changes	 in	 vessel	 permeability.41	 Hypoxia	 also	 may	 not	 be	 chronic,	 but	 rather	
fluctuate	 and	 vary	 spatially	 throughout	 the	 tumor.	 Along	 with	 deficiencies	 in	 delivering	
oxygen,	the	decreased	perfusion	also	leads	to	a	decreased	supply	of	nutrients	and	an	inability	
to	 remove	 metabolic	 waste	 products.	 Cancer	 cells	 have	 a	 high	 proliferative	 rate,	 which	
necessitate	energy	production	and	synthesis	of	biomolecules.	Although	glycolysis	may	be	
necessary	 due	 to	 hypoxia,	 it	 is	 an	 inefficient	 means	 of	 energy	 production.	 From	 these	
observations,	 tumor	 growth	 and	 metabolism	 are	 tightly	 regulated	 to	 the	 growth	 of	 the	
vasculature.	Further,	as	the	tumor	core	becomes	more	hypoxic,	necrosis	forms	and	that	area	
of	 the	 tumor	 becomes	 dormant	 due	 to	 the	 decreased	 proliferation.	 The	 process	 of	





Hypoxia	 triggers	 genetic	 changes	 such	 that	 signal	 transducer	 and	 activator	 of	
transcription	3	(STAT3),	an	 immunosuppressive	molecule,	 is	upregulated.	STAT3	 induces	

















in	 tumor	 cells	 leading	 to	 both	 increased	 tumor	 aggressiveness	 and	 heterogeneous	 cell	
populations	within	the	tumor.	Therefore,	even	if	oxygen	levels	are	restored	by	angiogenesis,	
 15 




Cancer	 exhibits	 unregulated	 cell	 growth	 and	 altered	 metabolism	 that	 is	 shifted	
towards	 aerobic	 glycolysis.41	 In	 normal	 tissue,	 glucose	 and	 oxygen	 are	 delivered	 by	 the	
vasculature	and	taken	up	by	cells.	Glucose	enters	the	glycolytic	pathway	and	is	converted	to	
pyruvate,	 producing	 2	 ATP	 in	 the	 process.	 In	 the	 presence	 of	 oxygen,	 pyruvate	 (the	 end	
product	of	glycolysis)	is	converted	to	acetyl-CoA	to	enter	the	TCA	cycle	and	fuel	oxidative	
phosphorylation	 in	 the	mitochondria,	 producing	 an	 additional	 30-34	ATP.	 	However,	 the	
metabolic	 phenotype	 of	 cancer	 is	 one	 of	 upregulated	 glycolysis	 and	 reduced	 oxidative	
phosphorylation.44	 Although	 this	 initial	 metabolic	 switch	 occurs	 early	 in	 cancer	
development,	the	driving	force	behind	the	metabolic	dysregulation	is	not	well	understood.	
The	upregulation	of	glycolysis,	as	the	first	metabolic	pathway	of	glucose	utilization	in	cells,	
necessitates	 increased	 glucose	 consumption	 to	 support	 increased	 biosynthetic	 needs.	 As	
tumors	grow	in	size,	areas	of	hypoxia	develop	prior	to	the	development	of	new	vasculature	
in	 the	 tumor	 (angiogenesis).	 In	 the	 absence	 of	 oxygen,	 pyruvate	 is	 converted	 to	 the	
byproduct	 lactate,	 in	 the	process	 reforming	NAD+	 to	be	 reused	 in	 the	glycolytic	pathway.	
Although	glycolysis	produces	NADH	from	NAD+,	 the	TCA	cycle	 is	the	primary	producer	of	
NADH	to	fuel	oxidative	phosphorylation	and	together	these	two	pathways	are	essential	for	
maintaining	 energy	 production	 over	 a	 range	 of	 oxygen	 tensions.	 Glycolysis	 is	 normally	










of	 these	 metabolic	 changes	 and	 act	 as	 a	 direct	 link	 between	 cancer	 genetics	 and	




a	 hallmark	 of	 cancer,	 rather	 than	 energy	 production	 as	 several	 signaling	 pathways	 are	
involved	 in	both	proliferation	 and	metabolism.	Proliferating	 cancer	 cells	 exhibit	 anabolic	
metabolism	and	add	to	the	tumor	mass	by	incorporating	nutrients	into	nucleotides,	amino	
acids,	and	lipids.	Although	uncontrolled	proliferation	is	normally	prevented	by	growth	factor	
regulation,	 cancer	 cells	 overcome	 the	 regulatory	mechanisms	by	 constitutively	 activating	
pathways	 leading	 to	 nutrient	 uptake.	 However,	 resistance	 to	 therapies	 that	 reduce	 the	
proliferative	 and	 replicative	 potential	 of	 tumors	may	 be	 due	 to	 acquired	mutations	 that	
change	the	metabolic	phenotype	to	relying	on	mitochondrial	function	to	a	greater	extent.48	
Oxidative	phosphorylation	is	accomplished	in	mitochondria	by	the	flow	of	electrons	through	
complexes	 anchored	 in	 the	 mitochondrial	 membrane.	 As	 oxidative	 phosphorylation	
decreases,	 the	 reduced	 function	 of	 the	 electron	 transport	 chain	 allows	 reactive	 oxygen	
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species	 (ROS)	 to	 form,	 which	 maintains	 the	 cancer	 cell	 phenotype	 and	 leads	 to	 further	
genetic	 instability,	 altered	 metabolism,	 and	 increased	 tumor	 invasion.	 Although	





Additionally,	 with	 the	 upregulation	 of	 glycolysis	 and	 decreased	 oxidative	
phosphorylation,	there	is	both	a	generation	of	protons	and	increased	lactate	production	that	
result	 in	 an	 acidic	 intracellular	 environment	 (Figure	 1.1).	 As	 acidity	 is	 toxic	 to	 cells,	
expression	of	Na+/H+	cotransporters	and	vacuolar	H+-ATPases	is	increased	to	neutralize	the	
intracellular	pH	and	shift	the	acidic	conditions	to	the	extracellular	environment.	However,	
exposure	 to	 acidic	 conditions	 in	 the	 extracellular	 environment	 promotes	 necrosis	 and	
apoptosis.	Since	carcinogenesis	is	accomplished	by	the	selection	of	specific	cell	populations	
with	 the	greatest	growth	advantage,	 selected	cancer	 cell	phenotypes	become	resistant	 to	
acid	 induced	cell	 toxicity.	The	glycolytic	phenotype	(including	extracellular	acidosis)	may	
offer	 a	 selective	 advantage	 to	 tumor	 cells	 because	 the	 acidic	 conditions	 are	 toxic	 to	
surrounding	cells	(not	adapted	to	survive	in	acidic	conditions).	Further,	the	low	pH	increases	
degradation	 of	 the	 extracellular	 matrix	 (ECM)	 by	 upregulating	 metalloproteinases	 and	
cathepsins,	 increasing	 invasiveness,	 again	 a	 hallmark	 of	 cancer.	 In	 total,	 the	 metabolic	






for	 maintaining	 the	 fluxes	 needed	 for	 lactate	 transport.	 There	 are	 also	 changes	 in	 lipid	
metabolism,	mainly	 in	 the	 carboxylation	of	 alpha-ketoglutarate,	 that	 are	 specifically	 seen	
with	isocitrate	dehydrogenase	(IDH)	mutations	in	GBM.		
Acidosis	in	the	tumor	microenvironment	has	been	associated	with	many	features	of	
cancer	 progression	 including	 remodeling	 of	 the	 extracellular	matrix,	 tumor	 invasion	 and	
metastatic	spread.7,8	Acidosis	leads	to	activation	of	proteases	that	disrupts	or	alters	adhesion	
proteins	 between	 cells	 and	 between	 cells	 and	 the	 matrix.	 Further,	 proteases	 found	 in	
lysosomes	 are	 most	 active	 under	 acidic	 conditions.	 Lysosomes	 may	 also	 be	 involved	 in	
removing	excess	protons	 from	the	cytosol	 if	upregulation	of	 transporters	was	not	able	 to	












to	a	decrease	 in	 the	extracellular	pH	(pHe)	along	with	an	 increase	 in	 the	 intracellular	pH	
(pHi).	The	decrease	in	pHe	leads	to	tumor	invasion	into	surrounding	tissue,	an	upregulation	
of	 angiogenesis	 leading	 to	 increased	 vascularization,	 and	 aids	 in	 creating	 an	
immunosuppressive	environment	resulting	in	immune	escape.	The	increase	in	pHi	results	in	









tumor	 microenvironment	 is	 complex	 and	 optimal	 for	 cancer	 cell	 survival,	 invasion,	 and	
metastasis.	A	unique	element	of	the	GBM	environment	is	the	presence	of	tight	junctions	on	









which	 supports	 tumor	 cells	 and	 creates	 a	 specific	 niche.31	 Integrins	 located	 on	 the	 cell	





the	 glycolytic	 switch,	 but	 is	 driven	 by	 both	 hypoxia	 and	 oncogene	 activation,	 primarily	







however,	 the	 tumor	 microenvironment	 is	 immunosuppressive	 and	 immune	 evasion	 is	
increasingly	becoming	evident	as	a	hallmark	of	cancer.53	
Solid	 tumors	 maintain	 an	 acidic	 extracellular	 environment	 with	 extracellular	 pH	





mutations	 in	 certain	 oncogenes,	 such	 as	 those	 found	 in	 GBM,	 upregulate	 lactate	




limit	 this	 alternate	 pathway,	 fully	 shifting	 tumor	 cell	 metabolism	 to	 the	 predominately	
glycolytic	phenotype.	Although	the	early	shift	 in	metabolism	is	not	entirely	understood,	 it	
results	in	the	selection	of	cell	populations	resistant	to	acid-induced	toxicity.	In	addition	to	
lactate	 production,	 protons	 are	 also	 generated	 by	 the	 hydrolysis	 of	 ATP	 and	 carbonic	
anhydrase	activity.	The	end	result	is	that	protons	and	lactate	accumulate	in	the	interstitial	
 22 
environment.42	 Further,	 the	 deregulated	 pH	 results	 in	 tumor	 growth	 and	 cancer	
progression.55	Specifically,	an	acidic	extracellular	pH	increases	proliferation,	angiogenesis,	
and	 invasion.	 In	gliomas,	 the	decreased	extracellular	pH	can	 increase	the	 invasiveness	by	
increasing	the	expression	of	extracellular	degrading	proteases	which	disrupts	the	basement	
membranes	of	the	extracellular	matrix,	promoting	tissue	invasion.56	
	 Although	the	acidic	extracellular	pH	originates	 from	within	the	tumor	habitat,	 it	 is	
also	thought	to	drive	local	invasion.57	The	direction	of	tumor	infiltration	directly	follows	the	
areas	with	the	lowest	extracellular	pH.	The	altered	pH	results	in	the	genetic	upregulation	of	
ionic	 transporters.	 Specifically,	 there	 is	 an	 upregulation	 of	 the	 Na+/H+	 cotransporter	 to	
remove	 protons	 from	 the	 intracellular	 environment	 and	 monocarboxylate	 transporters	
(MCTs)	 to	 remove	 lactate,	 shifting	 the	 acidity	 to	 the	 extracellular	 environment.58	
Additionally,	low	extracellular	pH	also	promotes	angiogenesis	through	interleukin	8	(IL-8)	
and	 VEGF.51	 As	 metastasis	 is	 the	 process	 where	 migratory	 cells	 invade	 the	 basement	












the	 tumor	 pH.61-63	 Low	 pH	 decreases	 sensitivity	 of	 radiation	 therapy,	 but	 can	 also	 be	
exploited	 to	 enhance	 delivery	 of	 weak-acid	 chemotherapy	 agents.56	 Further,	 the	 acidic	
extracellular	 pH	 has	 been	 exploited	 to	 deliver	 chemotherapy	 agents	 in	 an	 acidosis-
dependent	manner	such	as	with	the	use	of	low	pH	insertion	peptides	(pHLIP).	These	can	also	







Specifically,	 in	 GBM,	 acidic	 extracellular	 pH	 promotes	 a	 glioma	 stem-cell	 like	
phenotype	 through	 the	 impact	 of	 acidic	 pH	 on	 the	 tumor	 microenvironment.66	 Immune	
responses	can	also	be	impacted	by	acidosis	such	that	cytokine	production	by	activated	T	cells	
can	become	inhibited.67	There	is	metabolic	competition	in	the	tumor	microenvironment	as	











tumor	 microenvironment.	 Although	 immunotherapy	 is	 a	 novel	 approach	 to	 cancer	




other	 pharmaceuticals	 do	 not	 penetrate	 the	 CNS	 with	 high	 efficacy.	 Initial	 studies	 with	
immunotherapy	in	GBM	were	suboptimal	as	difficulties	with	treating	GBM	stemmed	from	a	
lack	of	understanding	of	tumor	biology,	metabolism,	and	the	microenvironment.	In	a	recent	
review	 of	 the	 difficulties	 with	 immunotherapy	 in	 GBM,	 many	 of	 these	 factors	 were	










inhibitors	have	 gained	 recent	 attention	 for	 their	 role	 in	promoting	 immune	 responses	 in	
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renal	 cancer,	 lung	 cancer,	 and	melanoma.	 PD-L1	 has	 been	 found	 in	 human	 gliomas	 and	






	 Further,	 a	 variety	 of	 other	 immune	 cells	 are	 impacted	 by	 the	 tumor	
microenvironment,	 specifically	macrophages	and	T	cells,	which	are	 the	 foundation	of	 the	
anti-tumor	 immune	 response.72	 In	 general,	 the	 tumor	 microenvironment	 is	
immunosuppressive	 and	 interrupts	 antigen	 presentation	 by	 downregulating	 MHC	
expression.	 Immunosuppression	 is	 achieved	 by	 inhibiting	 T	 cell	 proliferation	 and	 pro-
inflammatory	cytokine	release,	as	well	as	by	activating	regulatory	T	cells.	The	upregulation	
of	 glycolysis	 also	 creates	 an	 environment	 where	 glucose	 supply	 is	 restricted	 having	
significant	 consequences	 on	 T	 cell	 metabolism	 and	 inhibiting	 their	 ability	 to	 secrete	
cytokines.68	 Therefore,	 even	 if	 tumors	 are	 highly	 antigenic,	 the	 T	 cells	may	 not	 have	 the	
nutrient	source	in	order	to	respond	appropriately.	The	pro-inflammatory	cytokines	such	as	
interferon	 gamma	 (IFN-γ)	 and	 tumor	 necrosis	 factor	 alpha	 (TNFα)	 are	 downregulated	
through	IL-10,	an	immunosuppressive	cytokine.	The	immunosuppressive	cytokines	include	
IL-6,	IL-10,	and	TGFβ	and	their	secretion	is	upregulated	in	the	tumor	microenvironment.	In	
GBM,	 TGFβ	 promotes	 both	 tumor	 growth	 and	 invasion	 by	 promoting	 a	 GBM	 stem	 cell	
phenotype	 and	 angiogenesis.	 Hypoxia,	 through	 activation	 of	 HIF-1,	 will	 directly	 activate	
regulatory	 T	 cells	 (Treg)	 to	 modulate	 the	 immune	 response	 as	 well	 as	 promote	 the	
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differentiation	of	macrophages	into	tumor-associated	macrophages	(TAMs),	which	secrete	
immunosuppressive	cytokines.	Similarly,	acidosis	 results	 in	 the	decreased	release	of	pro-
inflammatory	cytokines	(TNFα	and	IFN-γ)	by	macrophages.67	In	summary,	the	entirety	of	the	
tumor	 microenvironment,	 which	 is	 driven	 by	 initial	 genetic	 mutations	 and	 altered	








between	 the	 intratumoral	 and	 peritumoral	 environment	 is	 steeper	 with	 less	 invasive	
tumors;	 therefore,	 the	pH	gradient	 can	be	used	as	a	marker	of	 tumor	 invasiveness.	More	
invasive	tumors	have	more	extensive	pH	abnormalities	and	the	acidic	pH	spreads	far	beyond	
the	tumor	boundary.76	The	genetic	mutations	driving	 initial	cancer	 formation,	 the	altered	
metabolism	resulting	in	the	upregulation	of	glycolysis,	and	the	variably	hypoxic	and	acidic	
tumor	 microenvironment	 are	 now	 all	 thought	 to	 be	 hallmarks	 of	 cancer	 and	 most	
interestingly,	 to	 each	 be	 related	 to	 one	 other.	 Further,	 the	most	 recent	 developments	 in	
cancer	 therapy,	 immunotherapy,	 are	 now	 being	 found	 to	 be	 dependent	 on	 the	 tumor	
microenvironment	as	hypoxia	and	acidosis	directly	impact	the	anti-tumor	immune	response.	
The	 role	 of	 developing	 novel	 techniques	 to	 image	 the	 tumor	microenvironment	 in	 both	
preclinical	models	and	 in	clinical	practice	will	only	become	more	relevant	and	of	greater	
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Acidification	 of	 the	 tumor	 microenvironment	 by	 altered	 cellular	 metabolism	 is	 a	






electrodes	 directly	 into	 surface	 tumors	 or	 using	 optical	 imaging	methods	 to	 noninvasive	
imaging	 methods	 using	 magnetic	 resonance	 imaging	 (MRI)	 and	 spectroscopy	 (MRS)	 or	
positron	 emission	 tomography	 (PET).	 Each	 technique	 has	 certain	 advantages	 and	
disadvantages,	vary	in	their	spatiotemporal	resolution,	and	may	use	endogenous	contrast	or	



























∆E = γℎB!		 	 	 	 (Equation2.1)	
For	an	ensemble	of	spins,	the	system	forms	an	equilibrium	and	it	is	the	difference	in	
number	of	spins	between	these	two	states	that	leads	to	a	non-zero	magnetization,	usually	














𝜔 = 𝛾𝐵!		 					 	 						(Equation	2.3)	




abundance.	 The	 1H	 nucleus	 is	 a	 notable	 exception	 with	 a	 net	 magnetic	 moment,	 a	 high	
gyromagnetic	 ratio,	 a	 natural	 abundance	 near	 100%,	 and	 an	 extremely	 high	 tissue	







Nuclei	 Spin	 Natural	Abundance	(%)	 Gyromagnetic	Ratio	(MHz/T)	
1H	 1/2	 99.985	 42.48	
19F	 1/2	 100	 40.08	
31P	 1/2	 100	 17.25	
23Na	 3/2	 100	 11.27	
13C	 1/2	 1.11	 10.71	
2H	 1	 0.015	 6.54	
17O	 5/2	 0.0373	 5.8	





























the	 relaxation	 parameters	 T1	 (longitudinal	 relaxation	 in	 the	 direction	 of	 B0)	 and	 T2	
(transverse	 relaxation	 in	 the	 xy-plane),	 which	 is	 detected	 as	 the	 MR	 signal.	 The	
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magnetization	 as	 a	 function	 of	 time	 is	 governed	 by	 the	 relaxation	 processes	 and	
mathematically	 represented	by	 the	Bloch	 equations.	The	magnetization	 in	 each	direction	
(Mx,	My,	or	Mz)	is	shown	in	Equation	2.4.	
dM)





















M. = M! 01 − e
2%&%$3	 	 		 						(Equation	2.5)	
T2	 is	 based	 on	 spin-spin	 interactions	 and	 loss	 of	 phase	 coherence	 due	 to	 the	
interaction	 between	 nearby	 spins	 and	 refers	 to	 the	 loss	 of	 the	 spin	 ensemble	 (i.e.,	 the	
magnetization)	 in	 the	 transverse	 plane.	 As	 the	 protons	 spin,	 they	 induce	 small	magnetic	





2%'%! 		 	 	 (Equation	2.6)	
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However,	magnetic	field	inhomogeneities	result	in	spins	losing	phase	coherence	even	
faster	 than	would	be	 expected.	The	observed	 transverse	 relaxation	 rate	 is	 called	T2*	 and	
accounts	 for	 the	 inhomogeneities	 that	 occur	 due	 to	 a	 variety	 of	 reasons	 including	
susceptibility	artifacts	in	tissues	or	the	presence	of	any	nearby	paramagnetic	materials.	The	
T2*	is	always	shorter	than	T2,	is	measured	in	a	different	manner	than	T2	and	can	be	beneficial	
if	 contrast	 agents	 that	 have	 strong	T2	 effects	 are	 used.	MRI	 acquisition	with	multiple	 TE	
values	 is	 used	 to	measure	 both	 T2	 and	 T2*	 using	 spin	 echo	 and	 gradient	 echo	methods,	
respectively.		














		 	 	 	 (Equation	2.8)	













acquired.	 The	 total	 delay,	 from	 excitation	 pulse	 to	 data	 acquisition	 is	 the	 TE.	 Due	 to	 the	






























time,	 the	 more	 signal	 that	 decays	 and	 it	 appears	 darker	 in	 the	 image.	 Other	 weighting	
measures	 can	 also	 be	 encoded	 in	 sequence	 design	 including	 proton	 density,	 apparent	
diffusion	coefficient	(ADC),	and	magnetization	transfer.	










provides	 a	 stable	molecular	 structure	 to	 deliver	 the	metal	while	 avoiding	 any	 undesired	




































directly	detect	 resonances	 that	emanate	 from	protons	on	 the	contrast	agent.	Gadolinium,	
however,	 is	 the	 most	 paramagnetic	 lanthanide	 agent	 and	 has	 much	 higher	 relaxivity,	
resulting	 in	 much	 shorter	 relaxation	 times.	 Additionally,	 the	 T2	 shortening	 results	 in	
significant	line	broadening	that	results	in	the	signal	being	undetectable	by	MRS.	Agents	with	
other	lanthanide	metals	(e.g.,	thulium),	while	less	paramagnetic,	have	relaxation	times	that	
result	 in	 less	 signal	 broadening	 and	 allow	 hyperfine	 shifts	 that	 can	 be	 directly	 detected.	
Lanthanide	agents	can	act	as	contrast	agents	by	shortening	relaxation	times,	but	 in	some	












bandwidth.	 The	 two	 in-plane	 directions	 (spatial	 encoding)	 are	 specified	 by	 frequency	










MRI	 voxel.79	 Diffusion-weighted	 imaging	 is	 based	 on	 the	 spin	 echo	 pulse	 sequence,	 but	
utilizes	an	additional	diffusion	encoding	gradient	before	and	after	the	180°	refocusing	pulse.	




b	 values)	 is	 based	 on	 the	 gradient	 strength	 (G),	 duration	 (d)	 and	 delay	 (D)	 according	 to	
Equation	2.10	when	using	symmetric	diffusion	gradient	pulses.	
b = γ-G-δ- =Δ − 6
7
?		 	 	 (Equation	2.10)	
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Similar	to	how	T2	is	measured	by	spin	echo	MRI	(Equation	2.6),	the	ADC	can	be	measured	
using	 a	 spin	 echo	 sequence	 by	 varying	 the	 b	 values	 to	 yield	 an	 exponentially	 decreasing	
function	governed	by	ADC	(Equation	2.11).	 	
M = M!e28(:;<)		 	 	 (Equation	2.11)	
In	solution,	diffusion	 is	unrestricted,	 resulting	 in	high	values	 for	ADC.	However,	 in	
cells	and	tissues,	the	inhomogeneous	environment	results	in	barriers	to	diffusion	due	to	cell	
membranes	and	the	tissue	structure	that	result	in	a	reduction	in	ADC.	In	cancer	imaging,	the	
ADC	 is	 linked	 to	 the	cellularity	of	 the	 tumor	as	more	highly	 cellular	 tumors	have	greater	
diffusion	restriction	and	lower	ADC	values.80	Heterogeneity	within	tumors	are	also	reflected	





exogenous	 contrast	 agent	 and	 uses	 a	 mass	 conservation	 equation	 to	 model	 vascular	
parameters	based	on	the	delivery,	exchange,	and	clearance	of	the	contrast	agent	in	different	
tissue	compartments.81	Contrast	agents	are	delivered	by	an	intravenous	injection	and	are	
present	 initially	 only	 in	 the	 blood.	 However,	 in	 some	 vasculature	 the	 contrast	 agent	

























		 	 	 (Equation	2.12)	
Analysis	 of	 DCE	 data	 can	 either	 rely	 on	 non-parametric	 analysis	 or	 parametric	
analysis.82	Nonparametric	approaches	are	used	most	commonly	clinically,	because	they	do	
not	rely	on	modeling,	but	rather	on	the	rate	of	signal	intensity	rise	or	area	under	the	curve	

























C1 = vHCH + v@C@		 	 																		(Equation	2.13)	








		 	 							 															(Equation	2.14)	
While	a	variety	of	other	models	have	been	proposed	and	tested,	they	largely	are	based	
on	making	assumptions	from	the	two-compartment	exchange	model.82	Limitations	of	these	




When	placed	 in	 an	 external	magnetic	 field,	 nuclei	within	 a	molecule	 experience	 a	
unique	 magnetic	 environment	 based	 on	 electron	 distributions	 and	 the	 presence	 of	
neighboring	nuclei.	The	magnetic	properties	of	nuclei	(resonance	frequency	and	relaxation	





magnetic	 field	(B0),	 the	effective	magnetic	 field	of	each	nucleus	(B)	 is	shown	in	Equation	
2.15	where	s	is	a	shielding	constant.				


















acquired)	 lead	 to	 both	 higher	 signal	 and	 sensitivity.	 Due	 to	 the	 lower	 concentration	 of	
metabolite	signals,	MRS	necessitates	a	lower	spatial	resolution	in	comparison	to	MRI.	
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NMR	 signal,	 a	 reference	 standard	 must	 be	 used	 (internal	 references	 being	 preferred).	
Further,	most	biologic	samples	are	inherently	inhomogeneous	and	the	NMR	signal	will	not	
be	 the	 same	 throughout	 the	 sample.	 Further,	 multiple	 spatial	 localizations	 are	 possible	
(similar	to	how	information	from	the	signal	can	be	encoded	in	space	for	MRI)	by	applying	
the	 RF	 pulse	 combined	 with	 phase	 encoding	 gradients	 in	 a	 technique	 termed	 magnetic	
resonance	 spectroscopic	 imaging	 (MRSI).	 Together,	MRI	 and	MRS	 are	 powerful	 tools	 for	





within	 tumors.	 In	 cancer	 imaging,	 pH	 dependent	 techniques	 are	 of	 critical	 importance	
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because	 of	 the	 acidic	 environment	 and	 the	 relationship	 between	 acidosis	 and	 tumor	














Intrinsic	 relaxation	 in	 MRI	 is	 not	 pH	 dependent.	 However,	 MRI	 relaxation-based	
methods	to	measure	extracellular	pH	have	been	attempted	using	lanthanide-based	contrast	












determined.87	 The	 pKa	 of	 phosphonates	 are	 in	 the	 physiological	 range	 and	 are	 therefore	



























yields	 quantification	 of	 pH.	 Other	 methods	 have	 been	 proposed	 to	 account	 for	 the	
concentration	 dependence	 in	 the	 relaxivity	measurement.	 Synthesizing	 Gd-DOTA-4	 Amp	






certain	 molecular	 functional	 groups	 (-OH,	 -NH,	 -NH2)	 in	 exchange	 with	 protons	 of	
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Therefore,	 this	 measurement	 relies	 on	 the	 presence	 of	 either	 endogenous	 or	
exogenous	 molecules	 that	 are	 CEST	 active.	 Diamagnetic	 agents	 (diaCEST)	 can	 be	 found	
naturally	and	include	amino	acids	and	sugars,	as	well	as	other	organic	molecules	containing	






concentration	 of	 the	 exchangeable	 protons.	 Exogenous	 diaCEST	 agents	 can	 also	 be	
administered	with	the	most	common	being	ipromide	and	iopamidol,	which	are	commonly	
used	contrast	agents	for	other	medical	imaging	modalities,	and	are	pH	sensitive.92		
Paramagnetic	 agents	 (paraCEST)	 contain	 lanthanide	metals	 and	 are	 based	 on	 the	
structure	 of	 the	 gadolinium-based	 contrast	 agents	 used	 clinically.93-95	 The	 benefit	 of	 the	
paraCEST	agents	is	that	the	resonance	frequency	of	the	exchangeable	protons	are	located	far	





core	 of	 the	molecule	 for	 CEST	 contrast.	 In	 all	 cases,	 the	 agents	 are	 designed	 so	 that	 the	
exchange	 rate	 is	pH	 sensitive.	However,	 due	 to	 the	 large	 chemical	 shift	dispersion	of	 the	
exchangeable	 proton	 groups,	 high	 B1	 fields	 are	 required	 for	 saturation	 and	 limit	 their	
translation	due	to	tissue	heating	concerns.		
When	 there	 are	 multiple	 exchange	 sites,	 either	 on	 the	 same	 molecule	 or	 in	 a	
combination	 of	 two	 molecules,	 a	 ratiometric	 approach	 can	 be	 utilized	 to	 eliminate	 the	
concentration-dependent	nature	of	the	pH	measurement.	A	ratiometric	approach	has	been	






do	 not	 require	 the	 administration	 of	 contrast	 agents,	 have	 low	 saturation	 power	
requirements,	and	are	based	on	readily	implementable	pulse	sequences	that	are	available	on	
clinical	 scanners.	 Therefore,	 amine	 and	 amide	 proton	 transfer	 has	 been	 studied	 on	
endogenous	pools	in	glioblastoma	and	has	shown	contrast	compared	to	surrounding	healthy	
tissue;	 however,	 absolute	 pH	 quantification	 from	 these	 methods	 remains	 challenging.	
Another	concern	with	exogenous	diaCEST	agents	is	the	necessity	for	large	concentrations	of	
the	CEST	agent	(>30	mM)	at	clinical	magnetic	field	strengths,	which	may	in	itself	alter	the	pH	
being	measured	 and	 is	 not	 practical	 for	 clinical	 applications.	 The	CEST	 effect	 in	 diaCEST	





amino	 acids98	 have	 been	 used	 to	 measure	 the	 pH	 in	 tumors,	 including	 GBM.	 Recent	




31P,	 19F,	 and	 1H	 MRS	 has	 been	 used	 to	 detect	 both	 endogenous	 and	 exogenous	




sensitivity,	 and	 there	 are	many	 phosphorylated	metabolites	 that	 can	 be	 detected	whose	
resonances	 are	 pH	 dependent.	 31P	 MRS	 was	 one	 of	 the	 first	 MR	 techniques	 applied	 for	
measuring	pH.	Specifically,	the	most	easily	detected	metabolites	are	Pi,	PCr,	and	ATP	and	the	
intracellular	pH	can	be	measured	because	the	difference	in	chemical	shifts	between	PCr	and	
Pi	 is	 pH	 dependent.101	 However,	 for	 measures	 of	 pHe,	 exogenous	 agents	 such	 as	 3-
aminopropyl	phosphonates	(3-APP)	are	required.75	3-APP	has	a	pH	dependent	chemical	shift	











measurement	where	 the	 chemical	 shifts	 of	 the	 19F	 resonances	 are	pH	dependent.103	 Like	
other	 MRS	 techniques,	 the	 sensitivity	 is	 low	 and	 requires	 delivery	 of	 a	 sufficient	








but	 also	 in	 nearly	 all	 metabolites.	 Many	 of	 these	 metabolites	 are	 present	 in	 the	 mM	
concentration	necessary	for	detection	and	can	be	detected	directly.	However,	no	detectable	
endogenous	1H	MRS	signal	is	inherently	pH	sensitive.	Although	in	vivo	measures	of	histidine	
have	 been	 attempted	 due	 to	 the	 presence	 of	 multiple	 pH	 sensitive	 resonances,	
concentrations	 are	 too	 low	 for	 accurate	 pH	 quantification	 requiring	 supplementing	 the	
signal	with	administered	histidine,	which	complicates	the	measurement	as	the	pH	measured	












of	 magnitude	 increase	 in	 sensitivity,	 the	 hyperpolarization	 is	 quickly	 lost	 at	 higher	
temperatures	with	T1	relaxation	times	of	less	than	1	min.	Therefore,	the	hyperpolarizer	must	
be	located	immediately	adjacent	to	the	MR	scanner	and	must	be	administered	immediately	


























pH	 electrodes	 work	 by	 using	 a	 H+-selective	 glass	 electrode	 to	 measure	 the	
concentration	of	H+	ions	and	convert	into	a	pH	value	on	a	logarithmic	scale.	pH	electrodes	
can	be	inserted	directly	into	tumors	to	measure	the	pH;	however,	this	is	a	highly	invasive	
procedure	 and	 each	 recording	 involves	 a	 new	 insertion	 requiring	 many	 recordings	 to	
spatially	map	pH.	Although	 these	may	be	considered	 the	gold	standard	because	 it	 can	be	
externally	calibrated	using	solutions	of	known	pH,	likely	these	measurements	are	a	weighted	






Optical	 imaging	methods	 are	 based	 on	 using	 pH	dependent	 fluorescent	molecules	
which	 can	 be	 detected	 using	 microscopy	 methods.	 Optical	 methods	 allow	 for	 rapid	
measurement	with	high	temporal	resolution	and	very	high	spatial	resolution.	However,	the	




pHLIP	 proteins	 insert	 into	 cellular	 membranes	 only	 at	 low	 pH	 (normally	 <6.5).113,114	
Therefore,	these	proteins	can	be	targeted	to	solid	tumors	where	the	pH	is	low.	The	pHLIP	
proteins	are	fluorescent	and	with	fluorescent	imaging,	regions	of	low	pH	can	be	identified;	





















radioactive	 isotopes	 (radiotracers)	 conjugated	 to	 molecules	 designed	 to	 target	 specific	
physiological	targets	in	the	body	and	is	used	as	a	molecular	imaging	tool.115	The	radioactivity	
is	 localized	 using	 the	 decay	 properties	 of	 the	 radiotracer	 and	 regions	 of	 radiotracer	







current	 approaches	 involve	 radiotracers	 that	 have	 been	 conjugated	 to	 pH	 low	 insertion	
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peptides	 (pHLIP)	 similar	 to	 those	 use	 for	 the	 optical	 methods	 described	 previously.	
Detection	of	these	proteins	that	insert	into	the	cell	membranes	in	a	pH-dependent	manner	
have	 been	 successfully	 used	 to	 identify	 acidosis	 in	 tumors.114,118,119	 However,	 due	 to	 the	
sigmoidal	nature	of	peptide	insertion,	these	methods	are	generally	non-quantitative	and	can	
only	 be	 used	 to	 determine	 if	 the	 pH	 is	 below	 a	 threshold	 value	 similar	 to	 their	 optical	
counterparts.	 Recently,	 18FDG	 has	 been	 synthesized	 to	 be	 in	 a	 molecular	 “cage”	 using	 a	
glycosylamine	linkage	that	is	released	in	a	pH-sensitive	manner	under	acidic	conditions,120	
demonstrating	 acidic	 conditions	 in	 tumors	 which	 can	 be	 increased	 through	 systemic	






with	 a	 corresponding	 alkalinization	 of	 pHi,	 in	 many	 tumor	 types	 and	 can	 be	 spatially	
heterogeneous.	The	pH	gradient	between	 the	 intratumoral	 and	peritumoral	 environment	
can	be	used	as	a	marker	of	tumor	invasion	into	surrounding	tissue	as	more	invasive	tumors	
have	acidic	pH	that	spreads	beyond	the	tumor	boundary.	Further,	through	the	combination	
of	 different	 imaging	 methods,	 pHe	 can	 be	 compared	 to	 aid	 in	 the	 confidence	 of	 the	
measurements	 as	 well	 as	 compare	 to	 other	 measures	 that	 are	 expected	 in	 acidic	
environments,	 such	as	a	correlation	with	 increased	 lactate	 levels	 from	1H	MRS.	However,	
each	imaging	modality	comes	with	differences	in	the	spatial	resolution	achievable,	the	need	
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chemical	 shifts	 of	 non-exchangeable	 protons	 on	 lanthanide-containing	 paramagnetic	
contrast	 agents.	 pH	 and	 temperature	 are	 physiologically	 relevant	 parameters	with	many	
medical	 applications.	As	discussed	 in	Chapters	1	 and	2,	 an	 acidic	 extracellular	 space	 is	 a	
hallmark	of	the	tumor	microenvironment,	where	acidosis	has	been	postulated	to	promote	
the	 aggressive	 and	 invasive	 characteristics	 of	 tumors	 and	 also	 inhibit	 the	 therapeutic	
response.	 Therapeutic	 hypothermia	 has	 applications	 in	 cerebral	 ischemia	 and	 traumatic	




evaluating	 the	 acidic	 pHe	 in	 glioblastoma	models	 in	 rodents	 in	 small-bore	 11.7T	 clinical	
scanners,	where	acidic	pHe	represents	tumor	invasion	in	untreated	tumors.	Since	there	are	
no	 other	 tomographic	 pHe	 mapping	 methods	 and	 directly	 altering	 pHe	 is	 difficult	 to	
implement,	we	looked	to	assess	the	quantitative	BIRDS-based	temperature	readout,	which	
could	be	compared	against	direct	temperature	recordings,	in	a	hypothermia	model	because	
temperature	 is	 much	 more	 easily	 altered	 than	 is	 pH.	 Selective	 brain	 cooling	 using	 an	
innovative	cerebrospinal	fluid	(CSF)	cooling	platform	was	used	to	induce	hypothermia	in	the	
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brain.	 Temperature	mapping	 of	 healthy	 sheep	 brain	 in	 wide-bore	 7.0T	 clinical	 scanners	
provided	dynamic	temperature	measurements	from	the	whole	brain.	The	brain	temperature	
decreased	 significantly	with	 cooling	over	 all	 defined	brain	 regions	 to	 levels	 known	 to	be	
neuroprotective,	 while	maintaining	 systemic	 normothermia,	 and	was	 in	 agreement	 with	
thermocouple	measurements.	Rapid	and	synchronized	temperature	fall/rise	upon	cooling	
onset/offset	was	observed	reproducibly	such	 that	dynamic	 thermal	mapping	can	provide	
high	 spatiotemporal	 temperature	 measurements	 to	 aid	 in	 optimizing	 selective	





shift	 towards	 glycolysis	 even	 in	 the	 presence	 of	 oxygen	 (Warburg	 effect)	 and	 immature	
vasculature	 that	 does	 not	 permit	 the	 clearance	 of	 waste	 products.41	 The	 reduced	
extracellular	 pH	 (pHe)	 has	 been	 associated	 with	 promoting	 tumor	 cell	 proliferation	 and	
promoting	 angiogenesis	 and	 invasion5,122-124	 as	 well	 as	 creating	 an	 immunosuppressive	
environment.33,125	Further,	 the	 low	pHe	 leads	 to	a	poor	response	 to	many	 therapies,7	 and	
neutralization	of	pHe	has	been	proposed	as	an	effective	therapeutic	strategy.126,127	Given	the	
important	contribution	of	extracellular	acidosis	to	shaping	the	tumor	microenvironment,	it	
would	 be	 desirable	 to	 be	 able	 to	 quantitatively	 and	 spatially	map	pHe	 for	 evaluating	 the	
metabolic	 state	 of	 the	 tumor	 and	 how	 metabolism	 changes	 during	 tumor	 growth	 and	
response	to	therapy.	
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	 Here	 we	 describe	 a	 magnetic	 resonance	 spectroscopic	 imaging	 (MRSI)	 technique	
termed	Biosensor	Imaging	of	Redundant	Deviation	in	Shifts	(BIRDS)	which	exploits	the	pH	
and	 temperature	 based	 dependent	 chemical	 shifts	 of	 non-exchangeable	 protons	 on	
lanthanide-based	contrast	agents	for	quantitative	pH	(and	temperature)	measurements.	
While	there	are	other	methods	that	have	been	developed	for	organ-wide	absolute	pH	
tomographical	measurement,	 there	 are	 several	 assumptions	 of	which	 to	 be	 aware	when	
comparing	pH	readouts	across	different	modalities	as	discussed	 in	Chapter	2.	First,	 some	
methods	 are	 weighted	 more	 towards	 extracellular	 pH,	 while	 others	 are	 weighted	 more	
towards	intracellular	pH.	31P	magnetic	resonance	spectroscopy	(MRS)	is	the	gold	standard	
for	 quantitative	 pH	 measurement;	 however,	 this	 method	 is	 heavily	 weighted	 towards	
intracellular	 pH	 because	 the	 readout	 is	 dependent	 on	 inorganic	 phosphate	 and	
phosphocreatine.75,128	 Further,	 the	 reduced	 sensitivity	 of	 31P	 necessitates	 large	 imaging	
volumes,	decreasing	 the	 spatial	 resolution	achievable.	Many	magnetic	 resonance	 imaging	
(MRI)	 methods	 are	 available	 for	 pH	 readout.	 A	 variety	 of	 chemical	 exchange	 saturation	
transfer	(CEST)	techniques	have	also	been	proposed	for	quantitative	pH	mapping.91,129-131	
The	CEST	readout	exploits	the	MRI	detectable	exchange	between	protons	in	dilute	pools	(of	
hydroxyl,	 amide,	 or	 amine	 protons	 in	 various	 endogenous	 or	 exogenous	molecules,	 both	
small	and	large)	and	bulk	water.	However,	the	diamagnetic	CEST	contrast	using	endogenous	









However,	 BIRDS	 is	 a	 unique	 method	 that	 achieves	 higher	 spatial	 resolution	 pH	
measurements	by	exploiting	the	higher	sensitivity	of	1H	MRI	with	the	specificity	of	1H	MRS.	
As	 explained	 below,	 due	 to	 several	 unusual	 features	 of	 BIRDS	 agents,	 the	 1H	MRSI	 data	
acquisition	 is	 acquired	 at	ultra-high	 speed	but	with	 little	 compromise	of	MRI-like	 spatial	
voxel	sizes.	
Contrast	 agents	 used	 for	 BIRDS	 are	 based	 on	 the	 macrocyclic	 structure	 used	 in	
commercially	 available	 gadolinium-based	 contrast	 agents.	 The	 pendant	 arms	 of	 these	
molecules	can	be	optimized	to	allow	for	greater	specificity	in	measuring	the	physiological	
parameter	of	interest	(e.g.,	pH	or	temperature).	For	example,	the	contrast	agent	TmDOTMA-	
is	 a	 carboxylate	 that	 only	 exhibits	 temperature	 dependence,	 whereas	 TmDOTP5-	 is	 a	
phosphonate	 that	 gives	 pH	 sensitivity	 (in	 addition	 to	 temperature).	 While	 many	





readout	 of	 pH	 is	 concentration-independent.	 The	 hyperfine	 shifted	 resonances	 of	 the	
detected	 resonances	 are	 diverted	 far	 from	 water	 (-140ppm,	 60ppm,	 and	 80ppm	 in	
TmDOTP5-)	 so	 that	 there	 is	 no	 overlap	 with	 any	 intrinsic	 metabolites,	 increasing	 the	
specificity	of	 the	measurement.	Further,	due	 to	 the	presence	of	multiple	detected	proton	
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resonances	 that	 shift	 in	 different	 directions	 with	 changing	 pH	 and	 temperature,	 the	











contrast	 agents	 remain	 extracellular,	 the	 measurements	 are	 weighted	 towards	 the	
extracellular	compartment.134	




The	 paramagnetic	 nature	 of	 these	 agents	 also	 provides	 T2	 contrast	 that	 can	 be	 used	 for	
relaxation-weighted	 MRI	 and	 some	 versions	 of	 these	 molecules	 include	 exchangeable	
protons	which	can	also	be	used	for	paramagnetic	CEST	applications.132		
BIRDS	is	limited	by	the	signal	to	noise	ratio	(SNR)	such	that	a	sufficient	concentration	









tumor	 into	 the	 surrounding	 tissue.	A	variety	of	 tumor	models22,25	 have	been	used	 in	 this	
regard	including	the	9L	and	RG2	models	that	are	used	in	immunocompetent	Fisher	rats	as	
well	 as	 the	 human-derived	 U87	 and	 U251	 models	 in	 Athymic/Nude	 rats.	 With	 this	
background	of	the	rational	for	BIRDS	pHe	and	temperature	mapping,	the	methodology	and	
technicalities	 will	 be	 discussed	 for	 performing	 BIRDS	 on	 preclinical	 tumor	 models.	 The	
methods	 will	 reflect	 the	 in	 vitro	 calibration	 of	 BIRDS	 and	 its	 application	 to	 the	 in	 vivo	
measurement	of	pHe	in	the	tumor	microenvironment.		BIRDS	was	also	further	developed	into	
a	 longitudinal	 pHe	mapping	 platform	 to	 allow	 for	 evaluation	 in	 changes	 in	 the	metabolic	
features	 of	 the	 tumor	 microenvironment	 during	 tumor	 progression.	 While	 all	 initial	






using	 cooling	 methods	 and	 can	 be	 compared	 against	 direct	 temperature	 electrode	
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recordings.	We	then	demonstrate	the	BIRDS	method	in	a	hypothermia	model	in	sheep.	While	
although	 a	 different	 application,	 these	 measurements	 demonstrate	 the	 dynamic	 and	





A	 database	 of	 thulium	 (III)	 1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetra(methylenephosphonate)	(TmDOTP5-;	Macrocyclics)	samples	are	needed	to	construct	
the	pH	and	 temperature	 calibration	 curves	 in	 vitro	which	 can	 then	be	applied	 for	 in	 vivo	
analysis.	The	characterization	is	performed	at	various	temperatures	and	pH	values.	All	data	





using	a	pH	meter	and	 the	pH	of	each	 sample	was	adjusted	using	 small	 volumes	of	dilute	
Hydrochloric	acid	(HCl;	Sigma)	or	Sodium	hydroxide	(NaOH;	Sigma).	For	each	pH	value,	data	
were	acquired	over	a	range	of	temperatures	(30-40	°C).	






shifts	 between	 sets	 of	 proton	 resonances.134	 For	 the	 best	 accuracy,	 the	 average	 of	
temperature	and	pH	calibrations	from	two	sets	of	proton	resonances	are	used	as	shown	in	


























prepared	by	varying	 the	 concentration	of	different	 ionic	 salts	by	adding	 sodium	chloride	
(NaCl;	Sigma),	potassium	chloride	(KCl;	Sigma)	or	calcium	chloride	(CaCl2;	Sigma).	The	ionic	





Since	 	 Ca2+	 does	 influence	 the	 chemical	 shifts,	 an	 in	 vivo	 concentration	 for	 Ca2+	 is	
assumed	to	be	1	mM	for	applications	of	the	calibration.134	Using	the	calibration	curve	yields	
spatial	pH	maps	in	vivo	that	are	representative	of	the	extracellular	pH	(pHe)	as	the	contrast	
agent	 does	 not	 cross	 the	 cell	membrane	 and	 therefore	 only	 reports	 on	 the	 extracellular	
environment.	However,	 in	 the	brain,	 the	agent	 is	 located	 in	 interstitial,	 vascular,	 and	CSF	
spaces	 and	 the	 pH	 reported	 will	 be	 a	 volume-weighted	 average	 of	 the	 pH	 in	 the	 voxel.	
Different	contrast	agents	can	be	used	with	the	BIRDS	method,	such	as	TmDOTMA-,	which	
only	 has	 chemical	 shift	 sensitivity	 to	 changing	 temperature.136	 However,	 any	 reporter	




















representative	 tumor.	 Although	 GBMs	 in	 the	 brain	 come	 with	 a	 variety	 of	 limitations	
regarding	access,	tumor	size	monitoring,	and	drug	delivery	due	to	the	presence	of	the	blood-













used	with	 cell-specific	 culture	and	 injection	protocols	 in	both	mice	and	 rats.22	All	 animal	
protocols	 and	 procedures	 are	 approved	 by	 the	 Yale	 University	 Animal	 Care	 and	 Use	




























and	the	 incision	site	 is	sanitized.	The	animal	 is	removed	from	the	stereotactic	holder	and	







to	 transferring	 the	 animal	 to	 a	 heating	 pad	 on	 the	 bench.	 Since	 the	 imaging	 procedures	
require	 the	 intravenous	 administration	 of	 contrast	 agents,	 a	 tail	 vein	 catheterization	 is	















with	 animal	 monitoring	 software	 (Small	 Animal	 Instruments).	 For	 sufficient	 anesthesia	
throughout	 the	 experiment,	 the	 respiratory	 rate	 should	 be	 maintained	 between	 30-60	
breaths	per	minute.		




animal	 to	maintain	 body	 temperature	 around	 37	 °C.	 For	 athymic	 rats	 (or	 other	 animals	
without	fur),	a	paper	towel	should	be	placed	between	the	animal	and	the	heating	pad	so	as	






the	 clinically	 used	 gadolinium	 contrast	 agents.78	 To	 increase	 the	 circulation	 time	 of	 the	
agents,	 renal	 clearance	needs	 to	be	decreased.	 In	 terminal	experiments,	 this	 can	be	done	








agent	 within	 the	 contrast-enhancing	 region	 of	 the	 tumor	 is	 largely	 unaffected	 by	 these	
strategies	 as	 the	 blood	 brain	 barrier	 is	 compromised	within	 the	 tumor	 and	 the	 agent	 is	
delivered	 to	 the	 tumor	even	without	 renal	 inhibition.	However,	 the	 contrast	 agent	 in	 the	
brain	is	greatly	reduced	without	methods	to	decrease	renal	clearance.		
A	stock	solution	of	probenecid	(Sigma)	is	prepared	at	a	concentration	of	100	mg/mL	
by	dissolving	probenecid	 in	0.5	M	NaOH.	The	pH	of	 the	 solution	 is	measured	using	a	pH	
meter,	and	then	adjusted	down	to	7.4	by	the	addition	of	saturated	KH2PO4	(Sigma).	A	single	
dose	(1.5	mL)	of	TmDOTP5-	(Macrocyclics)	is	prepared	fresh	before	each	experiment	based	






































scout	 images	 in	 three	 perpendicular	 imaging	 planes	 to	 serve	 as	 a	 fast	 localizer	 scan	 to	
position	the	animal	in	the	center	of	the	imaging	field	of	view	(FOV).	Next	a	rapid	acquisition	
with	 relaxation	 enhancement	 (RARE)	 sequence	 is	 performed	 where	 the	 power,	 shim,	
frequency	 offset,	 and	 receiver	 gain	 are	 optimized	 using	 automated	 setup	 features	 in	
Paravision.	 A	 point	 resolved	 spectroscopy	 (PRESS)	 sequence	 is	 used	 for	 second-order	
shimming	over	an	ellipsoid	ROI	using	the	B0	map	and	the	MapShim	feature	in	Paravision.	
Once	all	setup	is	complete,	the	imaging	experiments	can	begin	and	can	vary	based	on	which	
contrasts	 are	 desired.	 For	 BIRDS	 experiments	 for	 pH	 imaging,	 an	 anatomical	 image	 and	
spectroscopic	imaging	(MRSI)	sequence	must	be	acquired	at	a	minimum.	
A	 T2-weighted	 multi-slice	 spin	 echo	 sequence	 (MSME)	 is	 performed	 to	 generate	
anatomical	 images	 as	 well	 as	 quantitative	 T2	 maps	 (Figure	 3.2B).	 Imaging	 parameters	
include	a	repetition	time	(TR)	of	6	s	and	equally	spaced	echo	times	(TE)	ranging	from	10	to	






performed	 for	 anatomical	 coregistration	 (Figure	 3.2A).	 Coregistration	 is	 important	 for	
longitudinal	studies	where	the	same	animal	is	to	be	scanned	on	multiple	occasions	and	also	
if	 other	 imaging	 sequences	 (e.g.,	 DCE,	 CEST,	 etc.)	 necessitating	 different	 coil	 setups	 are	
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high	 and	 as	 such,	 a	 small	 surface	 RF	 coil	 is	 needed	 for	 efficient	 power	 transfer	 during	
excitation.	 Other	 acquisition	 parameters	 include	 a	 TE	 of	 285	 µs	 and	 a	 TR	 of	 5	 ms.	 The	
paramagnetic	agents	used	for	BIRDS	have	incredibly	short	T1	and	T2	relaxation	times	(<2	











in	 the	 tumor	 upon	 administration	 of	 the	 agent	 (See	 Figure	 3.2C).	 The	 contrast	 agent	
concentration	can	be	estimated	in	multiple	ways.	The	transverse	(r2)	relaxivity	of	the	agent	
can	be	measured	at	 the	given	 field	strength	and	the	T2	values	measured	before	and	after	






















All	 MR	 data	 is	 acquired	 and	 processed	 using	 Paravision	 software,	 while	 all	 post-
processing	 and	 data	 analysis	 is	 performed	 in	 Matlab	 (Mathworks)	 using	 custom	 scripts	
written	 in	 house	 for	 Bruker	 imaging	 systems.	 The	 Matlab	 scripts	 are	 integrated	 into	 a	
package	which	 allows	 for	 both	MRI	 and	MRSI	 datasets	 to	 be	 processed	 in	 a	 streamlined	
fashion.			
Reconstructed	 images	 from	 the	T2-weighted	 sequence	and	all	 imaging	parameters	
(FOV,	matrix	size,	number	of	averages,	position	offsets,	number	of	slices,	slice	thickness,	echo	
times,	and	repetition	time)	are	loaded.	The	signal	intensity	data	is	fitted	to	single	exponential	
functions	 to	 allow	 for	 quantitative,	 multi-slice,	 2D	 longitudinal	 (T1)	 or	 transverse	 (T2)	




parameters	 and	 geometric	 orientations	 are	 possible	 for	 image	 visualization	 and	
spectroscopic	evaluation.	
For	 analyzing	 BIRDS	 data,	 the	 anatomical	 images	 are	 visualized	 and	 appropriate	
regions	of	interest	(ROIs)	around	the	tumor	and	the	brain	are	manually	selected.	The	brain	
(white)	and	tumor	(black)	ROIs	are	outlined	on	the	anatomical	images	(See	Figure	3.2C).	To	
mask	 the	 MRSI	 data	 around	 the	 selected	 ROI,	 the	 resolution	 of	 the	 ROI	 from	 anatomic	
imaging	is	converted	into	the	resolution	of	the	MRSI	dataset	by	resampling	the	CSI	dataset	
at	the	same	resolution	acquired	for	the	anatomical	imaging	and	identifying	all	tumor	voxels.	




To	analyze	the	MRSI	data,	 the	raw	data	 is	output	as	a	“fid”	 file	when	using	Bruker	
software.	 The	 “slices”	 in	 the	 3D	 MRSI	 dataset	 that	 correspond	 to	 the	 slices	 from	 the	




the	 fft	 function	 in	 Matlab.	 On	 a	 voxel-by-voxel	 basis,	 the	 data	 are	 first-order	 baseline	
corrected	 around	 each	 peak	 by	 using	 the	 linfit	 function	 in	Matlab	 and	 zero-order	 phase	
correction	is	performed	around	each	peak	by	varying	the	phase	of	the	spectrum	from	0	to	
180º	 and	 choosing	 the	 phase	 that	 leads	 to	 the	 most	 symmetrical	 peak	 shape.	 Line	
broadening,	typically	300-500	Hz,	is	applied	to	each	peak.	Using	the	previously	created	ROIs	
at	the	resolution	of	the	CSI	dataset,	the	MRSI	data	is	masked	either	around	the	entire	brain	
or	around	the	 tumor	depending	on	the	area	of	 interest	 for	 the	particular	analysis.	Voxels	
outside	of	the	tumor,	in	the	otherwise	healthy	appearing	brain,	have	low	SNR	because	of	the	
agent	not	being	able	to	cross	the	blood	brain	barrier	in	large	amounts	resulting	in	low	tissue	
level	 concentrations	 (<0.5	 mM).	 Strategies	 can	 be	 employed	 to	 increase	 the	 agent	
concentration	in	the	brain	including	the	long	infusion	time	such	that	the	agent	concentration	
remains	high	in	the	vascular	compartment	setting	up	a	diffusion	gradient	from	the	vascular	









contrast	 agent	 could	 be	 detected.	 These	 processes	 can	 be	 largely	 automated	 in	 Matlab.	
However,	SNR	can	become	limiting	in	the	brain.	Further,	due	to	the	larger	size	of	the	voxels	
in	the	MRSI	scan,	the	factors	that	influence	the	chemical	shift	(namely	pH)	are	an	average	of	





different	 spatial	 analyses	 can	 also	 be	 performed.	 In	 this	 case,	 voxels	 on	 the	 tumor	
boundary/periphery	can	be	chosen	and	an	average	value	from	these	voxels	can	be	compared	
to	 intratumoral	 values.	 Additionally,	 a	 spatial	 distribution	 of	 values	 can	 be	 obtained	 by	
finding	 the	 center	 of	 mass	 (COM)	 of	 the	 tumor	 and	 then	 selecting	 all	 voxels	 in	 1	 mm	
concentric	circles	from	the	tumor	center	allowing	the	gradient	to	be	obtained.	Care	must	be	
made	when	interpreting	pH	values	from	voxels	that	contain	large	contributions	from	non-
tissue	 compartments	 including	voxels	at	 the	edge	of	 the	brain	where	 significant	vascular	
contributions	may	be	present	and	SNR	is	low,	as	well	as	voxels	that	include	the	ventricles	






aggressive	 tumor	 (RG2)	 having	 a	 lower	 pHe	 and	 the	 acidification	 extending	 beyond	 the	
anatomically-defined	tumor	boundaries.141	Studies	such	as	this	serve	as	the	foundation	for	
treatment	 studies	 where	 it	 was	 shown	 that	 temozolomide,	 a	 common	 alkylating	
chemotherapeutic	 agent	 used	 in	 the	 treatment	 of	 GBM	 was	 found	 to	 increase	 the	
intratumoral	pHe	closer	to	normal	values	(Chapter	5),	potentially	serving	as	a	biomarker	of	
the	 therapeutic	 response.142	 However,	 in	 these	 prior	 studies,	 renal	 ligation	 was	 used	 to	




both	 the	 context	 of	 untreated	 and	 treated	 tumors	 as	 described	 further	 in	 Chapter	 4	 and	
Chapter	5,	respectively.	Additionally,	pHe	is	a	difficult	physiologic	parameter	to	validate	in	
vivo	 and	 the	 changes	 observed	were	based	on	 in	 vitro	 calibrations.	However,	BIRDS	 also	
allows	for	temperature	measurements	either	alone	(using	TmDOTMA-)	or	 in	combination	
with	pHe	(using	TmDOTP5-).	Since	temperature	is	easier	to	manipulate	using	direct	cooling	
and	 can	 be	 compared	 to	 direct	 temperature	 recordings,	 the	 remainder	 of	 this	 chapter	









acquired	with	 the	 same	FOV.	Representative	 spectra	 in	 select	 voxels	 (iii)	 show	 the	 three	
distinct	resonances	of	TmDOTP5-.	From	the	CSI	data,	quantitative	pHe	maps	were	produced	
(iv)	that	show	an	acidic	pHe	within	the	anatomically-defined	tumors.	However,	in	the	more	





In	 traumatic	 brain	 injury	 and	 its	 concomitant	 ischemic	 injury,	 the	 promise	 of	
neuroprotection	 from	 therapeutic	 hypothermia	 remains	 elusive.	 The	 rapid	 and	 timely	
delivery	of	therapeutic	hypothermia	for	patients	with	traumatic	brain	injury	(TBI)	remains	
problematic.	 Two	 recent	 randomized	 clinical	 trials	 –	 EuroTherm	 3235	 and	 POLAR	 RCT-	
failed	to	show	a	treatment	effect	of	therapeutic	hypothermia	for	TBI.143,144	Unlike	patients	
with	 cardiac	 arrest	 or	 neonatal	 hypoxic-ischemic	 encephalopathy,	 where	 the	 timely	
application	of	hypothermia	provides	neuroprotection,	patients	with	brain	injury	present	a	
complex	 array	 of	 conditions	 and	 comorbidities,	 which	 hinder	 early	 application	 of	
prophylactic	hypothermia.	
Another	 potential	 confounding	 variable	may	 relate	 to	 the	method	 of	 hypothermia	
delivery	 itself.	 In	 many	 previous	 studies,	 including	 the	 two	 large	 randomized	 trials,	 the	
primary	 methodology	 to	 induce	 hypothermia	 was	 the	 use	 of	 intravenous	 solutions	 or	
endovascular	 devices	 to	 achieve	 systemic	 whole	 body	 cooling.	 Here	 we	 evaluate	 an	
innovative	technology	to	induce	localized	hypothermia	in	the	brain	to	temperatures	known	
to	be	neuroprotective,	while	maintaining	overall	systemic	(i.e.,	body)	normothermia.	
	 Physical	 and	 ischemic	 brain	 injuries	 result	 in	 inflammatory	 processes	 and	
dysregulated	 brain	 cooling	 mechanisms	 leading	 to	 brain	 temperatures	 higher	 than	
measured	 core	 body	 temperatures.145	 Therefore,	 decreasing	 the	 brain	 temperature	
(therapeutic	hypothermia)	has	been	shown	to	be	neuroprotective.	Therapeutic	hypothermia	
has	 demonstrated	 efficacy	 and	 has	 become	 a	 mainstay	 in	 treatment	 of	 global	 cerebral	
ischemia	 following	 cardiac	 arrest,	 with	 further	 evidence	 suggesting	 a	 neuroprotective	
 87 
benefit	 after	 TBI	 and	 ischemic	 stroke.	 Together,	 these	 conditions	 represent	 major	
contributors	to	morbidity	and	mortality	in	the	United	States.146	
Despite	 hundreds	 of	 unsatisfying	pharmacological	 attempts	 to	 identify	 drugs	with	
neuroprotective	 effects,	 hypothermia	 remains	 a	 viable	 therapeutic	 option	 that	 has	
demonstrated	 efficacy.	 Experimental	 studies	 in	 animal	 models	 of	 ischemic	 stroke	 have	
shown	a	clear	benefit	of	hypothermia	in	reducing	infarct	volumes.	Moreover,	hypothermia	
in	animal	models	of	TBI	has	demonstrated	neuroprotective	effects.147		





normal	 states.	 The	 greatest	 benefit	 of	 hypothermia	 is	 achieved	 in	 the	 time	 period	
immediately	 following	 the	physical	 or	 ischemic	 injury,	 and	 it	 is	 therefore	 critical	 to	 start	
treatment	immediately	upon	symptom/trauma	onset.	The	neuroprotective	effects	may	be	
lost	if	hypothermia	is	induced	after	reperfusion.	
Brain	 temperature	 is	 closely	 coupled	 to	 brain	 metabolism/perfusion,	 and	 tight	
temperature	 control	 is	 critical	 for	 normal	 brain	 function.145	 In	 animals,	 changes	 in	 brain	
temperature	of	2-3	°C	have	been	observed	with	behavioral	stimuli,	providing	a	link	between	
increased	brain	metabolism/activity	and	temperature.	There	is	a	close	relationship	between	
temperature	 and	oxidative	metabolism,	which	 is	 a	measure	of	 brain	 activity.152	 Although	






























for	 chilled	 saline	 to	 be	 pumped	 through	 a	 closed-loop	 catheter	 inserted	 into	 the	 lateral	
ventricles	of	the	brain.159	The	refrigerant	enters	by	one	lumen	of	the	catheter	and	exits	by	








within	 the	 brain,	 though	 usually	 lacking,	 are	 indeed	 required	 to	 understand	 the	
neuroprotective	effects	of	hypothermia,	for	example	when	particular	brain	regions	are	not	
being	 effectively	 cooled.	 Although	 there	 are	 both	 intraparenchymal	 and	 intraventricular	
temperature	probes	for	directly	monitoring	brain	temperature,	these	methods	allow	only	for	
localized	temperature	measurements	at	the	precise	site	of	the	temperature	probe.	Dynamic	
and	more	 comprehensive	measurements	of	 temperature	distributions	during	 cooling	 are	
necessary	 to	 understand	 the	 cooling	 efficiency	 of	 any	 cooling	 device	 prior	 to	 clinical	
translation.		
To	achieve	 this	we	have	used	Biosensor	 Imaging	of	Redundant	Deviation	 in	Shifts	
(BIRDS)	with	TmDOTMA-	to	yield	quantitative,	high-resolution	temperature	measurements	
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across	 the	 entire	 brain.134,136	 Using	 BIRDS,	 we	 measured	 the	 temperature	 maps	 in	 four	
healthy	sheep	brains	before,	during,	and	after	the	onset	of	cooling	induced	by	the	implanted	
CSF	cooling	device.	The	results	show	sustained	decreases	in	brain	temperature	across	both	
hemispheres	upon	 the	 onset	 of	 cooling,	with	 a	 return	 to	 baseline	 temperatures	 after	 the	
cessation	of	cooling.	Throughout	all	experiments,	systemic	normothermia	of	the	animals	was	
maintained.	 Thus,	 temperature	 mapping	 with	 BIRDS	 provided	 a	 direct	 measurement	 of	




Four	 juvenile	 crossbreed	neutered	male	 sheep	 (Ovis	 aries)	weighing	26.5,	 24.2	kg	
(age:	14	weeks),	34.5,	and	32.0	kg	(age:	22	weeks)	were	supplied	by	Thomas	D.	Morris,	Inc.	
(Reisterstown,	 MD,	 USA).	 The	 lambs	 were	 pair	 housed,	 provided	 with	 environmental	
enrichment,	and	acclimated	in	the	Yale	Animal	Resource	Center	(YARC)	for	9-10	days	prior	
to	surgery	and	imaging	procedures.	The	room	temperature	was	maintained	at	22.2	±1.1	°C	
with	 a	 photoperiod	 of	 12	 hours	 of	 light	 and	 12	 hours	 of	 darkness.	Water	 and	 hay	were	









Each	 fasted	 lamb	 was	 premedicated	 with	 acepromazine	 (0.05	 mg/kg)	 dosed	
intramuscularly	and	 then	 induced	with	ketamine	 (2.7	mg/kg)	and	diazepam	(0.2	mg/kg)	
intravenously	to	allow	endotracheal	intubation	and	subsequent	maintenance	on	isoflurane	
gas	 (1-3%)	 via	 mechanical	 ventilation.	 Buprenorphine	 (0.01	 mg/kg)	 was	 given	
intramuscularly	to	provide	opioid	analgesia	and	lactated	Ringers	solution	was	administered	
intravenously	 at	 the	 continuous	 rate	 of	 4ml/kg/hour	 for	 fluid	 maintenance.	 	 Thermal	
support	was	 provided	with	 a	 circulating	warm	water	 pad	 to	 control	 and	maintain	 body	
temperature	 (38-39	 °C),	 and	 an	 orogastric	 tube	was	 placed	 to	 allow	 venting	 of	 gas	 thus	
preventing	excessive	rumen	distension.		
Prior	to	the	initial	incision	a	local	anesthetic	injection	of	0.5%	bupivacaine	solution	
(1	 mg/kg)	 was	 made	 at	 the	 surgery	 site	 to	 provide	 multimodal	 analgesia.	 Continuous	
monitoring	of	 the	depth	of	anesthesia	and	stability	of	vital	signs	 in	 the	surgery	suite	was	
accomplished	 using	 a	Mindray	DPM6	patient	monitor	 (Mindray	DS	USA,	 Inc).	 Burr	 holes	
were	made	bilaterally	1.5	cm	anterior	and	lateral	to	the	posterior	fontanelle	at	an	angle	of	
10°	from	the	sagittal	plane	on	each	side.	A	pediatric	slotted	stylet	was	inserted	into	through	




a	 closed	 loop	 circuit,	 which	 is	 maintained	 at	 -7	 to	 -10	 °C.	 Additionally,	 the	 third	 lumen	
functions	as	an	external	ventricular	drain	(EVD)	for	intracranial	pressure	management.	This	
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lumen	 was	 modified	 to	 allow	 contrast	 agent	 infusion	 during	 the	 imaging	 procedures.	
TmDOTMA-	(7mg/kg)	was	infused	directly	into	the	lateral	ventricles	at	an	infusion	rate	of	
1ml/h.	Two	cooling	catheters	were	placed	via	the	burr	holes	directly	into	both	the	right	and	
left	 lateral	 ventricles	 (named	 right	 and	 left	 catheters,	 respectively).	 This	 technique	 is	
consistent	with	capabilities	of	common	clinical	practice	in	neurological	intensive	care	units.	
Continuous	 monitoring	 of	 the	 depth	 of	 anesthesia	 and	 vital	 signs	 in	 the	 MRI	 suite	 was	
accomplished	 using	 an	 Invivo	 Precess	 3160DCU	 patient	 monitor	 (Invivo	 Corporation	
Orlando,	 FL	USA).	 Following	 the	 completion	of	 the	 imaging	procedures,	 each	 animal	was	
euthanatized	with	an	intravenous	dose	of	sodium	pentobarbital-based	euthanasia	solution	
(Euthasol®).	
The	 magnetic	 resonance	 imaging	 (MRI)	 and	 spectroscopy	 (MRS)	 datasets	 were	









The	 CSI	 data	 was	 reconstructed	 to	 34x34x17	 resolution	 with	 a	 voxel	 size	 of	




𝑇 = 	𝑎+ + 𝑎-(𝛿RS7 + 103) + 𝑎7(𝛿RS7 + 103)-												(Equation	3.3)	
where	δCH3	is	the	measured	chemical	shift	of	the	methyl	resonance	of	TmDOTMA-	and	a1,	a2	
and	 a3	 are	 34.45±	 0.01,	 1.460±0.003	 and	 0.0152±0.0009,	 respectively,	 from	 linear	 least	
square	fitting	of	calibration	data	over	the	physiologic	range	of	temperature	values.136	The	
temperature	 from	 each	 voxel	 was	 measured	 and	 plotted	 in	 an	 axial	 slice,	 which	 was	
coregistered	with	anatomical	 imaging	to	show	the	spatial	distribution	of	 the	temperature	
values	throughout	the	brain.	 		




























The	subsequent	diverse	 time	courses	of	 temperature	change	 in	 individual	animals	
(when	flow	was	initiated	either	through	each	catheter	or	when	flow	was	increased	through	
both	 catheters)	 showed	 that	 BIRDS	 is	 able	 to	 capture	 dynamic	 changes	 in	 temperature	
throughout	cooling	and	is	indicative	of	the	robustness	and	reproducibility	of	the	method.		

















was	used	 for	 release	of	 the	CSF	pressure	 created	by	 the	expansion	of	 the	distensible	 sac	



















Figure	 3.5.	 Identification	 of	 specific	 brain	 regions	 as	 shown	 in	 a	 sheep	 brain	 atlas.	 The	











regions	 (Figure	 3.4D	 and	 Figure	 3.5),	 that	 were	 subsequently	 used	 for	 regional	
temperature	mapping	analysis.	The	regrouping	of	some	of	the	smaller	anatomical	regions	










BIRDS	 was	 successfully	 used	 for	 3D	 temperature	 mapping	 of	 sheep	 brain	 after	
administration	of	TmDOTMA-	at	a	resolution	of	4.5x4.5x9.0	mm3,	acquired	in	about	10	min	
and	repeated	throughout	several	cooling	and	recovery	processes	for	each	animal	(Figure	











temperature	 in	 all	 4	 animals	 shows	 reproducible	 temperature	 changes	 throughout	 the	
cooling	and	recovery	process	(Figure	3.7).	Although	brain	temperature	fluctuated	rapidly	
with	 the	 onset/offset	 of	 cooling,	 body	 temperature	 remained	 nearly	 constant	 and	
normothermic	 throughout	 the	duration	of	 the	experiment	 (Figure	3.6B).	The	water	bath	
temperature	used	to	maintain	the	body	temperature	 in	 the	anesthetized	animals	was	not	





Figure	 3.6.	 Representative	 example	 of	 temperature	 variation	 during	 intraventricular	
cooling	in	a	sheep	brain.	During	the	experiment,	several	baseline	temperature	maps	were	
obtained.	Temperature	maps	were	then	acquired	every	10	to	15	min	during	repeated	cooling	
and	 recovery	 cycles,	 using	 catheters	 lateralized	 to	 a	 single	 hemisphere	 or	 in	 both	
hemispheres.	At	the	end	of	the	experiment,	the	flow	rate	of	the	chilled	saline	through	the	
catheter	was	increased	from	35	to	42	mL/min	to	show	that	further	temperature	reductions	
could	 be	 achieved.	 Temperature	maps	 of	 a	 central	 sagittal	 slice	 before	 cooling	 (#),	 after	
































as	 global	 brain	 temperatures	 just	 before	 initiation	 of	 cooling.	 Nadir	 brain	 temperatures	



























Sheep	1	 38.9	±	0.3	 37.6	±	0.2	 33.9	±	0.4	 12.8	 9.8	 p<0.0001	
Sheep	2	 38.2	±	0.5	 38.3	±	0.2	 33.8	±	0.2	 11.4	 11.7	 p<0.0001	
Sheep	3	 38.5	±	0.2	 38.7	±	0.2	 35.7	±	0.2	 7.4	 7.9	 p<0.0001	
Sheep	4	 39.9	±	0.7	 39.5	±	0.3	 33.4	±	0.4	 16.3	 15.3	 p<0.0001	
	 	 	 	 	 	 	
Mean	 38.9	±	0.8	 38.5	±	0.7	 34.2	±	0.9	 12.0	 11.2	 p<0.0001	
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Global	 brain	 temperatures	 were	 measured	 as	 an	 average	 of	 all	 temperature	
measurements	over	the	entire	brain	(Table	3.1).	An	average	11%	decrease	(4.2	°C)	in	brain	
temperature	was	 observed	 in	 the	 four	 sheep,	while	 the	 brain	 temperature	 decreased	 an	
average	 of	 12%	 relative	 to	 core	 body	 temperature.	 The	 results	 of	 the	 temperature	
measurements	pre-	and	post-cooling	and	after	recovery	in	the	17	regions	are	shown	for	the	
left	(Figure	3.8A)	and	right	(Figure	3.8B)	brain	hemispheres.	The	differences	in	baseline	
temperatures	between	all	 regions	were	distributed	 throughout	a	0.7	 °C	 range.	Moreover,	
based	on	anatomical	 identification	of	brain	regions	using	 the	high-resolution	sheep	brain	
atlas,	 the	17	brain	 regions	were	 further	combined	 into	 two	main	regions:	one	superficial	
(termed	non-core)	and	one	deep	(termed	core)	(Figure	3.9).	We	employed	this	two-zone	










warmer	 than	 non-core	 regions	 (~0.2	 °C)	 but	 was	 not	 significant	 (p=0.26).	 Post-cooling,	
average	 brain	 temperature	 (including	 both	 core	 and	 non-core	 regions)	 decreased	













and	 post-cooling,	 and	 the	 recovery	 temperatures	 are	 reported	 for	 the	 17	 brain	 regions	
(shown	in	Figure	3.6)	as	average	+/-	SD	in	the	left	(A)	and	right	(B)	hemispheres	across	all	
animals.	Based	on	their	 location,	 these	17	brain	regions	were	 further	combined	 into	core	
(deep)	 and	 non-core	 (superficial)	 regions	 (Figure	 3.9).	 The	 core	 regions	 (subcortex,	
midbrain,	 occipital	 lobe,	 olfactory	 tract,	 parahippocampal	 cortex	 and	 temporal	 lobe)	 are	
identified	by	gray	circles	in	(A)	and	(B),	while	the	rest	are	the	non-core	regions.	The	average	
temperature	in	the	left	and	right	hemispheres	for	the	core	and	non-core	regions	is	reported	
before	 cooling,	 after	 cooling,	 and	 after	 recovery	 (C).	No	 significant	 changes	 are	observed	
between	the	right	and	left	hemisphere	of	the	brain.	Average	temperatures	across	the	entire	
brain	 (D)	 are	 also	 shown.	 In	 all	 regions	 and	 for	 the	 entire	 brain,	 statistically	 significant	



















Cooling	 using	 one	 intraventricular	 catheter	 resulted	 in	 a	 rapid	 temperature	 decrease	
throughout	 both	 core	 and	 non-core	 regions	 in	 each	 sheep	 (Figure	 3.10A).	 Similar	





-3.2±0.5	 °C	 and	 -3.1±0.5	 °C	were	 observed	 in	 the	 core	 of	 the	 left	 and	 right	 hemispheres,	
respectively	(Figure	3.10D).	In	the	non-core	regions	of	the	brain,	the	average	temperature	










event	 using	 the	 right	 catheter	 (A)	 and	 during	 the	 first	 recovery	 (B)	 in	 all	 four	 sheep.	
Quantification	of	the	absolute	change	in	temperature	during	cooling	and	recovery	are	shown	
for	 both	 the	 left	 and	 right	 hemispheres	 for	 core	 and	 non-core	 regions	 of	 the	 brain	 in	
individual	animals	(C).	Average	absolute	temperature	changes	are	reported	for	all	animals	










3.0±0.2	 °C	 and	 2.9±0.2	 °C	 (Figure	 3.10D).	 Although	 there	 are	 no	 significant	 differences	






(Equation	 3.4)	 was	 compared	 between	 core	 and	 non-core	 regions	 of	 the	 brain.	




Figure	 3.11C	 and	 3.11D).	 However,	 there	 were	 no	 differences	 between	 ipsilateral	 or	
contralateral	hemispheres	of	the	brain	relative	to	catheter	placement.	The	average	cooling	
rates	were	-0.082±0.009	°C/min	and	-0.080±0.010	°C/min	in	the	core	of	the	left	and	right	
hemispheres,	 respectively,	 while	 in	 the	 non-core	 regions	 the	 rates	 were	 -0.074±0.024	
°C/min	 and	 -0.079±0.026	 °C/min	 (Figure	 3.11D).	 The	 average	 recovery	 rates	 were	










Further	 temperature	 decrease	 was	 achieved	 either	 when	 we	 cooled	 using	 both	
catheters	or	when	we	increased	the	flow	rate	of	the	circulating	chilled	saline	(Figure	3.7).		

























Figure	 3.12.	 Effect	 of	 ROI	 volume	 on	 absolute	 change	 in	 temperature	 and	 rate	 of	 the	






Therapeutic	 hypothermia	 is	 neuroprotective;	 however,	 prior	 methods	 to	 achieve	
hypothermia	 rely	 on	 systemic	 body	 cooling,	 resulting	 in	many	 adverse	 effects.	 Although	
some	 targeted	 cooling	 methods	 have	 been	 proposed,	 their	 effects	 are	 modest.	 External	
cooling	devices	may	only	lower	brain	temperature	by	<1	°C.162	Further,	measuring	the	effects	
of	 hypothermia	 is	 challenging.	 With	 systemic	 body	 hypothermia,	 cooling	 measurements	
made	on	the	brain	surface	are	not	reflective	of	temperature	in	deep	brain	structures.	Since	
metabolism	continues	in	the	presence	of	hypothermia	to	varying	degrees,	the	temperature	





was	 stopped	 (recovery).	 The	 usage	 of	 a	 CSF-based	 intraventricular	 cooling	 catheter	
represents	an	innovative	method	for	brain	cooling.	In	a	prior	experiment,	we	demonstrated	
cooling	 of	 the	 brain	with	 this	 CSF-based	 technology.159	 Brain	 temperatures	 in	 that	 effort	
were	 measured	 by	 needle-based	 temperature	 sensors	 that	 were	 inserted	 into	 the	 brain	
parenchyma	at	a	depth	of	15	mm	posterior	and	anterior	to	the	ventricles.	As	those	results	
were	site	specific	and	required	an	additional	burr	hole	for	the	insertion	of	the	temperature	
sensor	 itself,	we	undertook	 this	current	effort	 to	achieve	a	more	comprehensive	and	 less	
invasive	mapping	of	cooling	throughout	the	brain.		
Measuring	the	cooling	rates	allows	for	a	dose-response	relationship	to	be	established.	













Other	 methods	 currently	 in	 use	 to	 induce	 hypothermia,	 such	 as	 intravascular	
infusions	of	chilled	saline/blood,	are	also	invasive	and	come	with	their	own	risks	and	may	
be	limited	in	the	degree	and	length	of	time	hypothermia	can	be	maintained.	In	contrast,	using	
a	 CSF	 cooling	 catheter,	 hypothermia	 could	 be	 maintained	 for	 as	 long	 as	 the	 catheter	 is	

























bore,	 allowing	 the	 saline	 solution	 to	 warm	 up	 while	 flowing	 through	 the	 delivery	 line.	
Therefore,	the	temperature	of	the	cooling	fluid	reaching	the	animal	was	warmer	than	in	our	












also	 demonstrate	 temperature	 fluctuations	 due	 to	 sleep,	 arousal,	 and	 stimulation.	 In	
addition,	under	anesthesia	there	are	also	differences	in	brain	temperature	from	the	awake	
state,	with	temperature	reductions	seen,	and	minimal	fluctuations	in	temperature.		











as	 phase	 shift	 MRI	 have	 been	 applied	 to	 monitor	 temperature	 changes	 in	 the	 brain.156	
However,	the	phase	shift	MRI	method	can	only	report	a	change	in	temperature,	and	not	the	
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local	 temperature	 was	 measured	 using	 thermocouples	 in	 four	 brain	 regions.	 The	
temperature	changes	(1.4	-	5.7	°C)	and	the	rates	recorded	are	similar	to	those	observed	here	
with	BIRDS.		
In	 terms	of	 changes	during	 cooling	 seen	within	 individual	 sheep	 in	 this	 study,	 the	
absolute	temperature	for	Sheep	4	decreases	much	more	than	in	the	other	three	sheep.	This	
can	be	attributed	to	the	baseline	temperature	being	higher	by	nearly	1	°C	in	this	animal.	Also,	
since	 the	 brain	metabolism	 competes	 with	 the	 cooling	 process,	 this	 higher	 temperature	
decrease	 could	 be	 due	 to	 a	 lower	 brain	metabolism	 in	 this	 sheep,	 possibly	 because	 of	 a	
deeper	state	of	anesthesia.	We	also	observed	that	the	absolute	temperature	for	sheep	1	and	
2	during	recovery	increased	by	about	1	°C	more	than	in	the	other	two	sheep	(Figure	3.10B	







secondary	 validation	 of	 the	 temperature	 changes	measured	with	BIRDS.	However,	 direct	
temperature	recordings	using	 the	same	cooling	system	have	been	made	previously	using	




between	 these	 two	measurements	must	 be	mindful	 of	 the	 following	 differences.	 For	 the	
thermocouple	measurements,	cooling	was	induced	using	two	catheters	(right	and	left)	with	
continuous	cooling	for	3	hr.	For	BIRDS,	cooling	was	varied	between	the	right	and	left	catheter	
(or	 both)	 and	 was	 stopped	 and	 started	 over	 the	 course	 of	 2	 hours	 to	 better	 study	 the	
dynamics	of	 the	 temperature	 changes	 induced	by	 the	 cooling	 catheter.	Moreover,	 for	 the	
thermocouple	 measurements,	 the	 temperature	 reported	 is	 an	 average	 value	 from	 four	
temperature	sensors	placed	in	the	anterior	and	posterior	cortex	of	both	the	right	and	left	
hemisphere,	while	 for	BIRDS	we	used	 the	average	cortical	 temperature.	 It	 should	also	be	










quantitative	 temperature	 mapping	 without	 other	 contributing	 factors.	 Systemic	 body	
temperatures	measured	by	a	rectal	probe	were	monitored	throughout	the	duration	of	this	
study	and	showed	only	minimal	changes	(±1	°C)	 in	systemic	temperature	throughout	the	
experiment	 (Figure	 3.6	 and	 Figure	 3.7).	 Note	 that	 typically	 animals	 under	 anesthesia	






ischemia	 following	 circulatory	 arrest.	 This	 provides	 positive	 implications	 for	 potential	
neuroprotection	in	TBI	and	ischemic	stroke.	Further,	hypothermia	has	been	a	mainstay	of	
surgical	procedures	involving	deliberate	cardiac	arrest,	including	many	forms	of	open	heart	






cooling,	 the	greater	 the	reduction	 in	oxygen	consumption,	and	 therefore	oxygen	demand,	





Sheep	#	 1	 2	 3	 4	 5	 1	 2	 3	 4	
Baseline	
T	(°C)	
38.7	 38.8	 38.2	 37.5	 37.8	 37.6	 38.2	 38.6	 39.4	
Cooling	
T	(°C)	
33.4	 37.3	 33.8	 31.8	 36.0	 35.7	 36.2	 35.7	 34.7	
Delta	T	
(°C)	
5.4	 1.4	 4.4	 5.7	 1.8	 1.9	 2.0	 2.9	 4.7	
%	
Change	







is	 the	 brain	 temperature	 just	 before	 initiation	 of	 cooling.	 The	 cooling	 temperature	 is	 the	
brain	temperature	after	cooling.	These	two	values	are	then	used	to	calculate	the	change	in	
temperature	 (ΔT)	 and	 the	 percent	 change	 in	 temperature	 from	 baseline.	 Note	 that	 the	




Ischemia	 leads	 to	neuronal	damage	 through	 several	mechanisms	 including	energy	
depletion,	excitotoxicity,	calcium	influx,	membrane	damage,	formation	of	free	radicals,	and	




Although	 questions	 will	 always	 remain	 about	 the	 optimal	 cooling	 methodology,	
targeted	temperature,	and	duration	of	hypothermia,	selective	and	targeted	cooling	strategies	









myriad	of	 successful	 animal	 studies	 in	TBI	 as	well	 as	 in	 other	morbidities,	 use	of	 topical	
cooling	has	been	unsuccessful.	However,	perhaps	 it	 is	not	 the	hypothermia	 itself	 that	has	
limited	the	translation	of	therapeutic	hypothermia,	but	rather	the	method	of	delivery	has	not	
been	effective.	The	use	of	 this	novel	CSF-based	cooling	platform	results	 in	significant	and	





induction	 of	 hypothermia.	 BIRDS	 allows	 for	 rapid	 imaging	 that	 has	 high	 temperature	











Glioblastoma	 progression	 involves	multifaceted	 changes	 in	 vascularity,	 cellularity,	
and	metabolism.	Capturing	such	complexities	of	the	tumor	niche,	from	the	tumor	core	to	the	
periphery,	 by	magnetic	 resonance	 imaging	 (MRI)	 and	 spectroscopic	 imaging	 (MRSI)	 has	
translational	 impact.	 In	 human-derived	 glioblastoma	 models	 (U87,	 U251)	 we	 made	
simultaneous	 and	 longitudinal	 measurements	 of	 tumor	 perfusion	 (Fp),	 permeability	
(estimated	with	 the	 transfer	 constant	Ktrans),	 and	volume	 fractions	of	 interstitial	 (ve)	 and	
plasma	(vp)	spaces	from	dynamic	contrast-enhanced	(DCE)	MRI,	cellularity	from	apparent	
diffusion	 coefficient	 (ADC)	MRI,	 and	 extracellular	 pH	 (pHe)	 from	 an	MRSI	method	 called	



















transverse	 (T2)	 or	 longitudinal	 (T1)	 relaxation	 times	 can	 elucidate	 potential	 changes	
between	tumor	and	normal	tissue	and	is	used	for	initial	clinical	identification	upon	symptom	




tumor	microenvironment	 that	may	 be	 reflective	 of	 treatment	 response.175	 Further,	 these	
imaging	contrasts	 largely	ignore	spatial	heterogeneity	as	tumors	are	extremely	diverse	in	





evaluate	 therapeutic	 response.	 In	 this	 study,	 we	 aim	 to	 demonstrate	 multi-modal	
longitudinal	characterization	of	 the	GBM	microenvironment	 in	preclinical	GBM	models	 to	
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highlight	 the	 spatial	 heterogeneity	 that	 exists	 in	 tumor	 cellularity,	 vascularity,	 and	
metabolism	and	how	it	changes	throughout	tumor	progression.	
Tumorigenesis	in	GBMs	is	highly	complex	and	involves	metabolic	changes	in	tumor	
cells	 and	 interactions	 with	 the	 surrounding	 microenvironment.	 GBMs,	 like	 other	 solid	
tumors,	 display	many	of	 the	hallmarks	 of	 cancer	 including	dysregulated	metabolism	and	
vascularization	which	drives	the	promotion	of	angiogenesis.2	Angiogenesis,	the	development	
of	new	blood	vessels,	occurs	in	tumors	in	response	to	the	development	of	hypoxia	and	to	aid	
in	 delivery	 of	 nutrients	 to	 the	 metabolically	 active	 tumors.	 However,	 the	 newly	 formed	
vasculature	 is	 tortuous	 and	 leaky.	 The	 tumor	 microenvironment	 is	 shaped	 by	 these	
abnormalities	 in	 the	 vascular	 architecture	 leading	 to	 heterogenous	 and	 inadequate	
perfusion.		
GBMs	are	highly	heterogeneous	due	to	tumor	growth	patterns	and	development	of	
necrosis.	 Spatial	 heterogeneity,	 not	 only	 in	 morphology,	 but	 also	 in	 perfusion	 and	
metabolism	may	contribute	 to	differing	patient	prognoses	and	 therapeutic	efficacy.	Thus,	
detecting	and	measuring	tumor	size	does	not	fully	capture	the	tumor	phenotype.	Hypoxia	
develops	 in	 specific	 regions	 of	 the	 tumor	 and	 contributes	 to	 tumor	 aggressiveness.	
Therefore,	imaging	methods	to	quantify	the	vascular	architecture	of	tumors	is	important	for	
tumor	 characterization	 and	 has	 been	 studied	 using	 a	 MRI	 technique	 termed	 dynamic	










Additionally,	 GBMs	 undergo	 a	 metabolic	 upregulation	 of	 glycolysis	 even	 in	 the	
presence	of	 sufficient	oxygen,	a	phenomenon	 termed	aerobic	glycolysis	 (Warburg	effect).	
This	leads	to	elevated	production	of	intracellular	acids	and	lactate,	which	are	then	extruded	
thereby	 acidifying	 the	 extracellular	 environment.3,41	 Specifically,	 extracellular	 acidosis,	
defined	as	a	reduction	in	the	extracellular	pH	(pHe)	in	relation	to	intracellular	pH	(pHi),		is	
an	 important	 indicator	of	 tumor	aggressiveness	as	the	reduction	 in	pHe	has	been	directly	
linked	 to	 increasing	 tumor	 invasiveness,	 reduced	 therapeutic	 response,	 increased	
angiogenesis	and	immunosuppression.8	 In	normal	brain	tissue,	the	pHe	 is	~7.2-7.4,	but	 in	
tumors	there	 is	a	drastic	reduction	 in	pHe	 to	~6.2-6.8.141	Metabolic	abnormalities	are	not	





well	 as	 pHe.86	While	 pH	 electrodes	 are	 the	 gold	 standard,	 a	 variety	 of	 imaging	methods	
including	optical,	PET,	 and	magnetic	 resonance	 imaging	and	spectroscopic	methods	have	
been	used	for	quantitative	pH	mapping.	However,	these	methods	vary	in	their	specificity	for	
pHe	 (vs	pHi)	 and	 their	 ability	 to	quantify	 the	pH.	 In	 this	 study,	 for	pHe	 imaging	we	use	a	
magnetic	 resonance	 spectroscopic	 imaging	 (MRSI)	 method	 called	 Biosensor	 Imaging	 of	
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Redundant	Deviation	in	Shifts	(BIRDS).	BIRDS	uses	the	pH-sensitive	chemical	shifts	of	non-






Quantitative	 BIRDS-pHe	 mapping	 has	 revealed	 highly	 acidic	 tumors	 where	 pHe	
changes	 can	 reflect	 tumor	 viability	 and	 response	 to	 therapy.141,142	 However,	 BIRDS-pHe	
mapping	 requires	 the	 use	 of	 paramagnetic	 contrast	 agents,	 such	 as	 thulium	 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetra(methylenephosphonate)	(TmDOTP5-),	and	limitations	
due	 to	 the	 need	 for	 sufficient	 contrast	 agent	 accumulation	 have	 previously	 prevented	






U251	 gliomas	 reproducibly	 and	 found	 that	 despite	 significant	 tumor	 growth,	 acidosis	
plateaus	early	in	tumor	formation	once	the	tumor	is	identifiable	by	imaging	methods.		




features	of	human	GBM	 in	different	aspects	 including	 the	development	of	necrosis,	 rapid	







acidosis	 in	 the	 tumor	 microenvironment	 in	 the	 same	 imaging	 space	 longitudinally	
throughout	 tumor	 progression,	 which	 enabled	 interrogating	 spatiotemporal	 changes	 of	
these	 parameters	 through	 tumor	 progression.	 We	 hypothesized	 that	 there	 would	 be	
restructuring	 of	 the	 vasculature	 over	 time	 in	 these	 models,	 and	 that	 metabolism	would	
change	 throughout	 progression.	While	 common	measures	 of	 tumor	progression	 are	 only	
tumor	 size,	 we	 hypothesized	 that	 these	 measures	 would	 provide	 additional	
characterizations	of	the	changing	tumor	microenvironment	that	were	not	solely	related	to	


















All	 animal	 protocols	 were	 approved	 by	 the	 Institutional	 Animal	 Care	 and	 Use	
Committee	 (IACUC)	 at	 Yale	 University.	 Female	 athymic/NUDE	 rats	 were	 acquired	 from	
commercial	 vendors	 (Envigo)	 and	 weighed	 150-250g.	 Animals	 were	 maintained	 in	




sterilized	 with	 betadine	 and	 70%	 ethanol.	 Local	 anesthetic	 (Bupivacaine,	 2	 mg/kg)	 was	
administered	prior	to	a	midline	incision	of	their	scalp.	After	exposing	the	skull,	a	hole	was	















10-15	 days	 after	 cell	 injection,	 animals	 underwent	 T2-weighted	MRI	 to	 check	 for	 tumor	








unless	 predetermined	 humane	 endpoints	 were	 met	 (e.g.,	 body	 weight	 loss,	 clinical	
neurological	signs),	in	which	case	the	animals	were	immediately	imaged	and	euthanized.		
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For	 the	multi-modal	 imaging	studies,	which	require	 the	administration	of	contrast	




inserted	 into	 the	 lateral	 tail	 vein	 of	 the	 rat	 and	 checked	 for	 backflow	 to	 ensure	 correct	
placement	within	the	vein,	prior	to	being	anchored	to	the	tail	with	tape.	Heparinized	saline	










performed	 using	 Bruker-defined	 gradient-echo	 (GE)	 and	 fast	 spin-echo	 (FSE)	 sequences.	
Shimming	was	done	on	an	ellipsoid	voxel	to	bring	the	H2O	linewidth	down	to	less	than	30	
Hz.	Quantitative	T2	mapping	was	performed	by	acquiring	T2-weighted	images	acquired	using	




function	 in	MATLAB.	 Quantitative	 T1	mapping	 consisted	 of	 T1-weighted	 images	 acquired	












39ms/2.5-5ms)	with	 a	 flip	 angle	 of	 15°	 every	 5	 seconds	 over	 22	min.	 At	 2	min	 into	 the	
dynamic	scan,	a	bolus	IV	injection	of	0.25mmol/kg	gadobutrol	(Gadavist,	Bayer	HealthCare	
Pharmaceuticals	Inc.),	a	clinically	available	macrocyclic	gadolinium	agent,	was	injected	and	
then	 flushed	with	 heparinized	 saline.	 For	 co-registration,	 DCE-MRI	 acquisition	was	 done	
over	three	central	slices	of	the	tumor	aligned	with	the	same	positioning,	FOV	(25	×	25	mm),	
and	matrix	(128	×	128)	as	the	T1	sequence.		
Measurements	 from	pre-contrast	 T1-weighted	 images	were	 used	 to	 transform	 the	








To	 measure	 vascular	 parameters	 [Ktrans	 (volume	 transfer	 coefficient,	 min-1),	 Fp	














mmol/kg	 TmDOTP5-.	 Probenecid	 was	 used	 to	 increase	 the	 plasma	 concentration	 of	 the	










BIRDS	 experiment,	 post-contrast	 quantitative	 T2	 mapping	 was	 performed	 such	 that	
reductions	in	T2	could	be	related	to	contrast	agent	concentration	and	T2	contrast	could	be	
used	for	identifying	tumor	margins.	Although	Gd3+	is	injected	earlier	in	the	experiment,	the	








a	 subset	 of	 tumors,	 tissue	 sections	 also	 underwent	 immunohistochemistry	 (IHC)	 for	
proliferating	cell	nuclear	antigen	(PCNA)	and	vascular	endothelial	growth	factor	(VEGF)	with	
hematoxylin	as	a	counterstain.	In	brief,	sections	were	deparaffinized	and	rehydrated	prior	
to	 antigen	 retrieval	 and	 peroxidase	 blocking.	 Sections	 were	 incubated	 with	 primary	
antibodies	(PCNA,	VEGF)	followed	by	incubation	with	a	biotinylated	secondary	antibody	and	












tumor	 cross-sectional	diameter	was	 selected.	The	 total	number	of	 voxels	 across	all	 three	




to	 the	 tumor	 margin	 (0	 is	 tumor	 margin	 or	 periphery,	 1	 is	 center	 of	 tumor).	 Various	
relaxation,	diffusion,	DCE	and	pHe	parameters	were	plotted	against	distance	from	the	tumor	














identify	 tumor	margins	 over	 all	 imaging	 slices	 (Figure	 4.1).	 After	 tumor	 detection,	 size	























Figure	 4.2.	 Longitudinal	 multi-modal	 imaging	 of	 U87	 and	 U251	 tumors.	 The	 apparent	
diffusion	 coefficient	 (ADC)	 maps	 reflect	 cellularity,	 the	 Ktrans	 maps	 from	 DCE	 reflect	
vascularity,	and	the	pHe	maps	from	BIRDS	reflect	acidosis.	Imaging	was	performed	at	three	
different	timepoints	in	the	same	U87	(A)	and	U251	(B)	tumors.	The	tumor	was	masked	using	




Quantitative	 T1	 and	 T2	 relaxation	 maps	 were	 acquired	 across	 all	 time-points	 in	
addition	to	the	advanced	vascular	and	metabolic	imaging	methods.	In	both	U87	(Figure	4.3)	
and	U251	 (Figure	4.4)	 tumors,	 T1	 and	T2	 values	were	 higher	 in	 the	 tumor	 compared	 to	
surrounding	tissue.	T1	values	between	tumors	were	not	significantly	different	at	 the	 final	
time	point	(p=0.22),	but	increased	with	tumor	progression	from	the	initial	to	final	timepoint	
for	both	 tumor	 types	 (U87:	2.24±0.13	 s	 vs.	 2.53±0.07	 s,	 p<0.0001;	U251:	2.19±0.09	 s	 vs.	
2.47±0.04	s,	p=0.0009).	For	T2	the	values	between	tumors	were	moderately	different	at	the	
final	time	point	(p=0.026),	but	there	was	a	trend	in	increasing	T2	with	tumor	progression	for	
both	 tumors	 types	 (U87:	 41.3±2.9	 ms	 vs.	 43.3±2.1	 ms,	 p=0.16;	 U251:	 38.5±2.5	 ms	 vs.	
41.0±1.5	ms,	p=0.06).	
		 Tumors	displayed	contrast	enhancement	(CE	T1)	and	significantly	(p<0.001)	reduced	
T1	 values	within	 the	 tumor	core	after	gadobutrol	 infusion	on	T1-weighted	 images	 in	U87	
(Figure	4.3)	 and	U251	 (Figure	4.4)	 tumors.	 For	CE	T1	 values	between	 tumors	were	not	
significantly	 different	 at	 the	 final	 time	 point	 (p=0.26).	 CE	 T1	 increased	 with	 tumor	
progression	for	U87	(1.12±0.10	s	vs.	1.29±0.16	s,	p<0.03)	but	not	for	U251	(1.27±0.20	s	vs.	
1.16±0.25	 s,	 p=0.43).	 U87	 tumors	 displayed	 homogenous	 signal	 enhancement	 that	 was	
confined	by	the	tumor	margins	(Figure	4.3);	however,	U251	tumors	exhibited	much	greater	
heterogeneity	in	enhancement	patterns	with	contrast	accumulating	in	central	tumor	regions	
as	well	 as	 leaking	 into	 surrounding	 brain	 tissue,	 resulting	 in	 contrast	 enhancing	 regions	
changing	based	on	 time	since	contrast	agent	administration	(Figure	4.4).	These	patterns	
were	reflected	in	post-contrast	quantitative	T1	mapping	such	that	with	tumor	progression,	
U87	 tumors	 had	 higher	 post-contrast	 T1-values	 than	 U251tumors.	 This	 was	 somewhat	
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Figure	4.3.	Multi-slice,	multi-parametric	 imaging	of	U87	tumors.	All	data	 is	 from	a	single	
imaging	session	for	a	single	animal.	Cellularity	(ADC),	vascularity	(Fp,	Ktrans,	ve,	vp	with	DCE)	
and	 metabolism	 (pHe	with	 BIRDS)	 as	 well	 as	 quantitative	 T2	 and	 pre/post-contrast	 T1	
mapping	are	included.	Three	imaging	slices	were	used	for	all	imaging	contrasts,	allowing	for	









and	 metabolism	 (pHe	 from	 BIRDS)	 as	 well	 as	 quantitative	 T2	 and	 pre/post-contrast	 T1	
mapping	are	included.	Three	imaging	slices	were	used	for	all	imaging	contrasts,	allowing	for	





	 Quantitative	 ADC	maps	were	 generated	 across	 3	 imaging	 slices	 at	 each	 timepoint	
from	 diffusion-weighted	 imaging	 at	 multiple	 b	 values.	 Since	 ADC	 has	 been	 shown	 to	 be	
correlated	with	tumor	cellularity,80	the	ADC	was	used	as	an	indication	of	the	proliferative	
status	of	U87	(Figure	4.3)	and	U251	(Figure	4.4)	tumors.	ADC	parameter	distributions	were	
homogeneous	 for	 both	 tumor	 types.	 ADC	 values	 between	 tumors	 were	 not	 significantly	
different	at	the	final	time	point	(p=0.26),	nor	did	they	change	for	either	tumor	between	time	






DCE	 parameters	 the	 values	 between	 tumors	 were	 not	 significantly	 different	 at	 the	 final	













Time	Point	1	 12.43±1.34			 22.14±11.17	 0.21±0.07	 0.028±0.016	
Time	Point	3	 14.48±	5.90	 50.74±40.27	 0.20±0.06	 0.038±0.043	
p	value	 0.39	 0.09	 0.72	 0.54	
U251	
Time	Point	1	 8.89±4.11	 14.41±7.09	 0.35±0.17	 0.063±0.051	
Time	Point	3	 12.20±2.61	 23.19±8.96	 0.25±0.10	 0.045±0.031	










Signal	 enhancement	 after	 gadobutrol	 administration	 corresponded	 to	 regions	 of	
signal	 darkening	 after	TmDOTP5-	 in	T2-weighted	 images	providing	multiple	 contrasts	 for	
measuring	 tumor	 size.	 Further,	 coinfusion	 of	 probenecid	 and	 TmDOTP5-	 allowed	 for	
successful	repetitive	pHe	mapping	in	the	same	tumor	for	the	first	time.	At	all	timepoints,	the	
intratumoral	 pHe	 was	 lower	 (pH	 6.1-6.8)	 than	 the	 pHe	 of	 the	 brain	 parenchyma	 (~7.1)	
indicating	 that	 the	 intratumoral	 microenvironment	 becomes	 acidic	 early	 during	 tumor	
growth,	once	the	tumor	becomes	detectable	by	imaging	methods.	However,	longitudinal	pHe	
mapping	using	BIRDS	revealed	that	as	tumors	become	larger	there	is	no	clear	corresponding	
change	 in	 pHe.	 Acidosis	 developed	 early	 during	 tumor	 formation	 and	 remained	 acidic	
throughout	 tumor	 progression.	 Across	 all	 timepoints,	 the	 average	 pH	was	 higher	 in	U87	
compared	to	U251	(6.54±0.08	vs.	6.47±0.14;	p=0.046).	 	In	U87	tumors,	larger	tumors	had	
the	same	pHe	as	smaller	 tumors	(6.56±0.05	vs.	6.56±0.09,	p=0.94)	while	 in	U251	tumors,	
larger	 tumors	 were	 slightly	 more	 acidic	 although	 this	 was	 not	 found	 to	 be	 statistically	
significant	 (6.44±0.15	 vs.	 6.58±0.06,	 p=0.12).	 The	 pHe	 remained	 relatively	 homogenous	
throughout	 the	 tumor	with	minimal	spatial	variation.	The	pHe	at	 the	core	of	both	tumors	














Figure	 4.5.	 Spatial	 and	 temporal	 variation	 in	 parameter	measurements	 throughout	 U87	
tumor	progression.	With	progression,	 tumor	volume	 increases.	The	spatial	distribution	 is	
determined	by	measuring	the	distance	from	the	tumor	margin	(0	is	tumor	margin,	1	is	center	
of	tumor).	Measurements	include	cellularity	(ADC),	vascularity	(Fp,	Ktrans,	ve,	vp	 from	DCE)	




















With	 increased	 tumor	 progression	 (increasing	 volume),	 there	 was	 a	 significant	
increase	in	intrinsic	T1	 in	both	U87	and	U251	tumors.	However,	there	was	a	homogenous	
distribution	of	the	T1	and	T2	relaxation	measurements	across	U87	tumors	 independent	of	












In	 U87	 tumors,	 there	 was	 much	 greater	 homogeneity	 in	 the	 vascular	 parameter	
values.	 The	 interstitial	 and	 plasma	 volume	 fractions	 tended	 to	 decrease	 with	 tumor	
progression,	indicating	increased	cellularity.	Tumor	progression	also	led	to	an	increase	in	
plasma	flow,	while	vascular	permeability	(estimated	by	Ktrans)	remained	constant.	Although	






In	U251	 tumors,	 there	were	notable	differences	 in	 the	 interstitial	 volume	 fraction	
with	tumor	progression.	With	tumor	progression,	the	interstitial	volume	fraction	increased	
significantly	 in	 deeper	 regions	 of	 the	 tumor.	 This	 corresponded	 with	 a	 reduced	 plasma	





ve	 were	 comparable	 between	U87	 and	U251	 tumors	 and	 showed	 increasing	 values	with	
tumor	progression	that	was	most	pronounced	at	the	growing	edge	of	the	tumor.	In	both	U87	
and	U251	tumors,	Fp	exhibited	similar	increasing	trends	during	tumor	progression,	but	at	all	










intensity	 on	 T1-weighted	 images	 where	 contrast	 agent	 accumulates.	 Necrosis	 was	 not	
observable	in	U87	tumors.	Regions	of	increased	proliferation	(yellow	stars)	are	highest	on	





U87	and	U251	tumors	were	characterized	 in	 terms	of	 their	cellularity,	vascularity,	
and	 metabolism	 throughout	 tumor	 progression	 with	 multi-parametric	 MRI/MRSI	
methodology.	Few	longitudinal	studies	on	preclinical	glioma	models	have	been	performed	






microenvironment,	 with	 pHe	 values	 ranging	 from	 6.1	 to	 6.8,	 developed	 by	 the	 initial	
timepoint	 early	 during	 tumor	 progression	 and	 remained	 homogenous.	 However,	 U251	
tumors	were	found	to	be	slightly	more	acidic,	suggesting	that	U87	tumors	are	metabolically	
less	glycolytic.	
During	 tumor	 progression,	 spatiotemporal	 patterns	 of	 parametric	 values	 were	




changes	were	more	pronounced	 for	U251	tumors.	Although	Ktrans	 remained	 lowest	at	 the	
tumor	margin	 of	 both	 tumors,	well-perfused	 regions	 developed	 in	 central	 tumor	 regions	
between	the	periphery	and	core	with	U87	tumors	exhibiting	higher	Fp.	Although	there	was	
no	 change	 in	 average	 values	 for	 ve	 and	 ADC	 with	 progression,	 regions	 with	 reduced	 ve	
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corresponded	well	with	 lower	ADC	 (higher	 cellularity)	 in	U87	 tumors;	 for	U251	 tumors,	
regions	with	higher	ve	and	higher	ADC	were	observed	in	the	core	suggesting	development	of	
necrosis.		
	 Despite	 U87	 and	 U251	 tumors	 being	 extensively	 used	 in	 the	 literature,	 different	
growth	patterns	are	evident	in	many	reports.24,26,190	Differences	in	time	to	tumor	formation	
results	 from	 the	 difficulty	 of	 injecting	 large	 numbers	 of	 cells	 in	 small	 volumes.	 A	 larger	
number	of	cells	(5x105	cells	in	5	µL)	are	injected	for	the	U251	model	compared	to	U87	(2x105	





The	 size	 of	 the	 tumor	 based	 on	 contrast	 enhancement	 depends	 on	 the	 time	 from	
contrast	agent	administration	until	measurement.	Previous	work	comparing	the	tumor	size	
from	 contrast-enhanced	 imaging	 revealed	 the	 difference	 in	 size	 based	 on	 the	 time	 from	
contrast	administration	with	differences	observed	up	to	30%	greater	at	late	time	points.191	
Although	late	enhancement	T1-weighted	images	were	acquired,	the	volume	was	calculated	
based	 on	 demarcation	 of	 the	 tumor	 margin	 on	 T2-weighted	 images	 for	 consistent	
measurements	between	the	tumor	types.	Additionally,	the	DCE	was	acquired	in	only	three	
1-mm	slices,	which	in	small	tumors	would	cover	the	entirety	of	the	tumor	and	could	be	used	





and	 washout	 from	 the	 tumor	 and	 relate	 these	 changes	 to	 local	 perfusion	 and	 vascular	
permeability.	Both	U87	and	U251	are	well-vascularized	tumors.	Well-perfused	regions	(Fp)	
developed	 between	 the	 periphery	 and	 tumor	 core	 with	 U87	 tumors	 exhibiting	 higher	
perfusion	 rates,	 but	 permeability	 (Ktrans)	 remained	 lowest	 at	 the	 tumor	margin	 for	 both	








Central	 regions	 of	 U251	 tumors	 had	 reduced	 cellularity	 as	 reflected	 by	 decreased	
hematoxylin	 staining	 on	 H&E;	 however,	 U87	 tumors	 showed	 no	 evidence	 of	 necrosis.	
Necrotic	 areas	 on	 H&E	 corresponded	 to	 regions	 of	 higher	 ADC	 and	 increased	 ve	 also	
suggestive	of	reduced	cellularity	as	expected	with	necrosis.	While	both	U87	and	U251	are	
positive	for	PCNA,	as	validated	with	IHC,	U251	has	much	greater	proliferation	at	the	tumor	
margin.	 Further,	 PCNA	 is	 expressed	 at	 high	 levels	 in	 peritumoral	 tissue	 in	 U251	 tumors	
indicative	of	proliferative	cells	outside	of	the	demarcated	tumor	boundary.			







the	 margin	 and	 center	 of	 the	 tumor)	 compared	 to	 U87	 tumors,	 which	 is	 supported	 by	
increased	VEGF	staining.	
The	 acidic	 microenvironment	 (pHe	 6.1-6.8)	 developed	 early	 during	 tumor	
progression	and	remained	homogenous.	U251	tumors	were	more	acidic,	suggesting	higher	
glycolytic	metabolism	in	U251	than	U87	tumors.	Although	the	pHe	remains	stable	or	slightly	





tumor	 growth.	 U87	 has	 a	 well	 demarcated	 tumor	 margin	 that	 remains	 well	 defined	
throughout	tumor	progression	indicating	minimal	invasion	into	the	surrounding	tissue.	In	
contrast,	 U251	 tumors	 have	 a	 poorly	 defined	 tumor	 margin,	 contrast	 leaks	 into	 the	
surrounding	 tissue,	 and	ADC	and	T2	 values	 are	higher	 in	 the	peritumoral	 region,	making	
measuring	spatial	variations	in	pHe	at	the	tumor	margin	important	for	characterizing	tumor	
invasion	 into	 surrounding	 tissue.	 However,	 pHe	 distributions	 remain	 homogenous	
throughout	tumor	progression	and	a	stable	marker	of	tumor	metabolic	output.	
Our	 surface	 fitting	 ignored	 which	 tumor	 was	 associated	 with	 which	 animal,	 and	










volume)	 as	 well	 as	 the	 spatial	 dimension	 (distance	 to	 tumor	 boundary).	 However,	 the	
extraction	 of	 rich	 results	 (fitted	 surfaces	 in	 our	 case)	 from	 any	 given	 data	 comes	 at	 the	
potential	tradeoff	of	overfitting,	thus	requiring	optimal	design	choices.	One	of	these	was	the	





Our	data	 is	not	a	random	sampling	of	voxels	 from	across	an	 inordinate	number	of	
tumors,	but	 rather	 is	a	collection	of	many	voxels	 from	single	 tumors	 in	multiple	animals.	
While	data	 from	multiple	 tumors	and	animals	were	used,	all	 the	voxels	 from	each	tumor,	
being	 from	 the	 same	 tumor,	 would	 naturally	 show	 some	 correlation.	 We	 have	 more	
datapoints	across	a	range	of	distances	from	tumor	boundary	that	across	a	range	of	tumor	
progressions/time	 points/tumor	 volumes.	 The	 result	 of	 this	 is	 that	 trends	 along	 the	



















mapping	 using	 BIRDS.	 Although	 the	 ADC/DCE	 and	 BIRDS	 datasets	 were	 acquired	 with	
different	RF	coils,	animal	positioning	was	standardized	to	ensure	that	the	same	regions	were	
imaged	in	both	datasets	and	were	acquired	in	the	same	imaging	session.	The	slices	used	from	
the	 BIRDS	 dataset	 were	 acquired	 with	 the	 same	 thickness	 as	 for	 the	 ADC	 and	 DCE	
measurements	such	that	they	represent	similar	tumor	regions.	Although	minor	rotations	in	
the	animal	positioning	prevent	the	slices	acquired	from	the	two	methods	to	exactly	overlap,	
they	 represent	 the	 same	 tumor	 depths	 and	 spatial	 orientation.	 The	 tumor	 was	 masked	
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Vascular,	 cellular,	 and	 metabolic	 imaging	 provides	 rich	 information	 on	 the	
microenvironment	during	 tumor	progression	 in	GBM.	For	example,	although	U87	 tumors	
grew	two	times	faster,	U251	tumors	were	more	aggressive	as	indicated	by	their	prolonged	
and	reduced	perfusion	and	pHe,	a	combination	of	which	could	be	related	to	necrotic	cores.	In	
addition	 to	 changing	 morphologic	 architecture	 and	 cellularity,	 the	 tumor	 vascular	
microenvironment	showed	a	reduction	in	extracellular	volume,	increased	plasma	flow,	and	
greater	heterogeneity	 throughout	 tumor	progression.	Using	a	 combination	of	probenecid	
and	TmDOTP5-	 allows	 for	 successful	 longitudinal	 BIRDS	pHe	 quantification.	 Interestingly,	
despite	 the	 morphologic	 and	 vascular	 remodeling,	 metabolic	 output	 remains	 stable	 and	
equivalently	 glycolytic	 as	 evident	 by	 constant	 pHe,	 with	 the	 acidic	 microenvironment	
developing	 early	 in	 tumor	 growth	 and	 remaining	 acidic	 during	 tumor	 progression.	 This	
suggests	 the	potential	of	pHe	 as	a	biomarker	of	 tumor	metabolism	that	 is	 independent	of	
tumor	size	and	may	in	future	studies	be	used	to	monitor	treatment	response.	The	dynamic	
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As	 seen	 in	 Chapter	 4,	 gliomas	 maintain	 an	 acidic	 extracellular	 pH	 (pHe),	 which	
promotes	 tumor	growth	and	builds	 resistance	 to	 therapy.	Given	evidence	 that	 acidic	pHe	
beyond	the	tumor	core	indicates	infiltration,	we	hypothesized	that	imaging	the	intratumoral	
pHe	in	relation	to	the	peritumoral	pHe	can	provide	a	novel	readout	of	therapeutic	influence	
on	 the	 tumor	microenvironment.	We	used	Biosensor	 Imaging	 of	 Redundant	Deviation	 in	





apoptosis	 induction	 (cleaved	 Caspase-3	 staining;	 p<0.001)	when	 compared	 to	 untreated	
rats.	The	DpHe	was	 significantly	higher	 in	untreated	 compared	 to	 treated	 rats	 (p<0.002),	
suggesting	 that	 temozolomide,	 which	 induces	 apoptosis	 and	 hinders	 proliferation,	 also	
normalizes	 intratumoral	 pHe.	 We	 also	 used	 BIRDS	 for	 longitudinal	 pHe	 mapping	 in	 rats	
treated	with	sorafenib,	 a	 tyrosine	kinase	 inhibitor.	Treated	U87	 tumors	displayed	slower	
tumor	 growth	 and	 increased	 pHe	 (p=0.01)	 within	 4	 days	 of	 starting	 therapy;	 however,	
sorafenib-treated	tumors	exhibited	reduced	agent	extravasation.	In	summary,	BIRDS	can	be	














however	 resistance	 to	 temozolomide	 arises	 by	 the	 presence	 of	 O6-methylguanine	 DNA	
methyltransferase	 that	 is	 able	 to	 repair	DNA	methylation	damage.	Despite	 temozolomide	
being	the	only	approved	chemotherapeutic	agent	to	show	a	survival	benefit,	anti-angiogenic	
agents	 including	 both	 the	 anti-VEGF	monoclonal	 antibody	 bevacizumab	 and	 a	 variety	 of	




Thus,	 having	 reliable	 markers	 and	 methods	 to	 assess	 therapeutic	 response	 is	 of	









imaging	 (CSI)	 platform	 where	 paramagnetically-shifted	 non-exchangeable	 protons	 on	 (-




models.	 First,	we	 evaluate	 effects	 of	 TMZ	 in	 U251	 gliomas	 by	measuring	 pHe	 inside	 and	







Agilent	 (Santa	 Clara,	 CA)	 11.7T	 horizontal-bore	 spectrometer,	 using	 a	 1H	 surface	 radio-
frequency	(RF)	coil	(1.4	cm	diameter).	U87	scans	were	conducted	on	the	same	system	but	
operating	Bruker	(Billerica,	MA)	software	and	using	a	transmit/receive	coil	 in	addition	to	
the	 same	 surface	 coil.	 TmDOTP5-	 (1,4,7,10-tetraazacyclododecane-1,4,7,10-
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tetrakis(methylene	 phosphonate)	 complexed	 with	 thulium)	 was	 purchased	 from	
Macrocyclics	(Dallas,	TX,	USA),	Gadobutrol	was	obtained	from	Bayer	(Whippany,	NJ,	USA),	
TMZ	was	obtained	from	Sigma-Aldrich	(St.	Louis,	MO,	USA)	and	sorafenib	was	obtained	from	






athymic	 nude	 rats	 (200-250	 g;	 n	 =19),	 maintained	 according	 to	 approved	 animal	 care	
protocols,	 were	 anesthetized	 with	 isoflurane	 (2-3%)	 and	 positioned	 in	 a	 stereotaxic	
instrument.	Cells	were	washed	and	suspended	in	serum-free	media	and	a	5	µL	volume	of	the	








mg/kg)	was	 administered	 via	 oral	 gavage	 daily	 until	 terminal	 imaging.	MR	 imaging	was	



















agent	 injection	 to	obtain	a	relative	change	 in	 the	 intensity.	The	volume	of	 the	 tumor	was	
assumed	to	be	equal	to	the	volume	of	the	region	where	the	relative	intensity	change	is	larger	







anchored	 to	 the	 tail	 with	 tape.	 Each	 rat	 underwent	 bolus	 injection	 of	 Gadobutrol	 (~0.4	
mmol/kg)	 to	 estimate	 the	 tumor	 volume	 from	 increased	MRI	 signal	 (T1	 contrast)	 due	 to	
Gadobutrol	extravasation.		
At	22-24	days	after	 tumor	 inoculation	 (~3	weeks)	each	rat	underwent	 infusion	of	
TmDOTP5-	 (~0.4	mmol/kg)	 for	 pHe	 imaging	 and	 the	 tumor	 volume	was	 estimated	 from	
decreased	MRI	signal	(T2	contrast)	due	to	TmDOTP5-	extravasation.141	The	anesthetized	rats	
were	prepared	as	described	earlier	with	renal	ligation	to	maintain	a	high	concentration	of	
TmDOTP5-	 (slowly	 infused	 at	 0.5-0.7	 mL/hr	 using	 a	 syringe	 pump)	 during	 BIRDS	
experiments.194,195	 Ventilation	 was	 adjusted	 to	 maintain	 normal	 physiology.	 Body	
temperature	was	measured	with	a	rectal	probe	and	no	 further	adjustments	 in	 the	water-
heated	pad	were	made	for	the	entire	duration	of	the	experiment	(~2	hrs).		
Tumor	 acidity	 was	 measured	 using	 the	 BIRDS	 technique	 described	 previously.	
133,134,141	 In	 short,	 chemical	 shift	 imaging	 (CSI)	 for	BIRDS	was	performed	 to	measure	 the	
chemical	shifts	of	the	pHe-dependent	proton	resonances	of	TmDOTP5-	to	calculate	pHe	within	
each	voxel	at	an	isotropic	resolution	of	1mm3.	A	205	μs	dual-banded	Shinnar-Le	Reux	pulse	








applied	 overnight	 at	 4	 °C	 for	 Ki-67	 (1:25,	 Abcam,	 ab66155)	 and	 Caspase-3	 (1:25,	 Cell	
Signaling	 Technology,	 #9661).	 The	 sections	 were	 incubated	 with	 a	 goat	 anti-rabbit	
secondary	 antibody	 (1:500,	 Pierce,	 #31460)	 for	 60	minutes	 followed	 by	 incubation	with	











128	 ×	 128	 matrix.	 The	 T1	 sequence	 was	 then	 repeated	 after	 0.25	 mmol/kg	 gadoterate	













The	 arterial	 input	 function	 (AIF)	 was	 measured	 by	 collecting	 arterial	 blood	 samples	 at	
discrete	 time	 points	 post-injection	 in	 a	 representative	 animal.	 A	 hematocrit	 of	 0.45	was	
assumed	for	deriving	the	contrast	agent	concentration	in	the	blood.	The	raw	AIF	was	fit	to	a	
bi-exponential	curve	and	applied	to	the	analysis	for	all	datasets.	A	region	of	interest	(ROI)	
was	placed	 in	 the	 tumor,	which	was	 the	 area	used	 for	 all	 analyses.	 To	measure	 vascular	
parameters	 [Ktrans	 (volume	 transfer	 coefficient,	 min-1),	 Fp	 (plasma	 flow	 rate,	 min-1),	 ve	







concentration	of	 the	 circulating	 contrast	 agent	 and	 reduce	 its	 rate	 of	 renal	 clearance.	All	
infusions	were	performed	using	a	syringe	pump	at	a	rate	of	15	µL/min	for	a	total	infusion	
time	of	 100	min.	 Chemical	 shift	 imaging	began	45	min	 after	 the	 start	 of	 the	 infusion.	All	













Tumor	 size	 was	 measured	 by	 MRI	 contrasts	 generated	 from	 water	 proton	
longitudinal	(T1)	and	transverse	(T2)	relaxation	enhancements.	The	effect	of	TMZ	on	U251	
tumor	growth	was	assessed	by	measuring	the	tumor	volume	at	~2	weeks	(i.e.,	12-14	days	
using	 T1-enhanced	 contrast	 by	 Gadobutrol)	 and	 ~3	 weeks	 (i.e.,	 22-24	 days	 using	 T2-
enhanced	 contrast	 by	 TmDOTP5-)	 post	 tumor	 inoculation	 (Figure	 5.1A).	 In	 the	 treated	
group,	the	rats	were	imaged	at	12.6±0.5	and	22.8±0.7	days,	whereas	in	the	untreated	group	
the	rats	were	imaged	at	12.4±2.2	and	22.0±3.3	days.	Recent	experiments	indicate	that	tumor	
volumes	 measured	 with	 a	 T1	 agent	 (e.g.	 Gadobutrol)	 are	 nearly	 identical	 with	 those	
measured	using	a	T2	agent	(e.g.	TmDOTP5-)	in	the	same	rat.88	Ambiguity	exists	in	delineating	
tumors	 in	 clinical	 images	 with	 ill-defined	 tumor	 boundaries.	 However,	 U251	 tumors	 in	
rodents	 have	 a	 tumor	mass	with	 fairly	well-defined	boundary.	 Thus,	 ambiguity	 in	 tumor	




(5.2±1.2	µL)	and	3	weeks	 (3.9±0.9	µL)	 (Figures	5.1A	and	5.1B).	Thus,	 tumor	sizes	were	




before	 TMZ	 treatment	 was	 67.5%,	 which	 reduced	 to	 10.5%	 following	 TMZ	 treatment	
(p<0.03)	 indicative	 of	 reduced	 proliferation.	 Cleaved	 Caspase-3	 staining	 before	 TMZ	
treatment	 was	 2.5%,	 which	 increased	 to	 15.5%	 following	 TMZ	 treatment	 (p<0.001)	
suggesting	 apoptosis	 initiation.	 Expression	 of	 MCT-4	 was	 analyzed	 in	 a	 representative	






Figure	 5.1.	 Effect	 of	 TMZ	 treatment	 on	 U251	 tumor	 morphology,	 apoptosis,	 and	
proliferation.	(A)	T1-	and	T2-weighted	MRI	at	~2	and	~3	weeks	post	 tumor	 implantation,	
respectively,	depicting	tumor	sizes	in	untreated	and	TMZ	treated	U251	tumors.	(B)	Tumor	














The	 tumors	 were	 localized	 by	 T2	 contrast	 as	 a	 result	 of	 TmDOTP5-	 extravasation	 from	
immature	 tumor	vasculature.133,135	Treated	tumors	appeared	smaller	 in	size	compared	to	
untreated	 tumors	 (Figures	 5.2A	 (i)	and	 5.2B	 (i);	 see	 also	Figures	 5.1A	and	 5.1B).	 The	
proton	resonances	of	TmDOTP5-	 in	the	corresponding	imaging	slice	are	shown	in	Figures	
5.2A(ii)	and	5.2B	(ii).	As	the	permeability	and	clearance	rates	of	TmDOTP5-	vary	in	different	
tissues,	 the	 peak	 intensities	 vary	 across	 the	 different	 regions	 in	 the	 image.	 As	 reported	







observed	 immediately	 adjacent	 to	 the	 tumor	 boundary	 in	 untreated	 tumors.	 This	 is	



















precautions	 to	 report	 the	 intratumoral	 and	 peritumoral	 pHe	 values	 accurately.	 In	 small	
tumors,	 where	 many	 voxels	 intersect	 the	 tumor	 boundary	 defined	 by	 MRI,	 partial	
contribution	from	the	non-tumor	area	can	confound	the	results.	Thus,	voxels	that	contained	




to	 a	 Gaussian	 distribution	 to	 obtain	 the	 most	 probable	 pHe	 and	 the	 full	 width	 at	 half	
maximum	(FWHM)	of	these	histograms.	The	most	probable	intratumoral	pHe	values	were	
higher	 in	 treated	 when	 compared	 to	 untreated	 tumors.	 The	 FWHM	 values	 of	 untreated	
tumors	 (~0.4)	were	 higher	 than	 treated	 tumors	 (~0.3),	 indicating	 heterogeneous	 pHe	 in	
untreated	rats,	which	is	normalized	by	TMZ	in	treated	rats.	Figure	5.3C	shows	the	average	
values	 of	 intratumoral	 and	 peritumoral	 pHe	 in	 treated	 and	 untreated	 rats.	 Average	
intratumoral	pHe	was	 significantly	 (p<0.01)	 lower	 in	untreated	 rats	 compared	 to	 treated	






Figure	 5.3.	 Distribution	 of	 pHe	 values	 in	 untreated	 and	 temozolomide	 treated	 tumors.	
Intratumoral	(gray	bars)	and	peritumoral	(black	bars)	regions	are	shown	for	untreated	(A)	
and	 TMZ	 treated	 (B)	 U251	 tumors.	 Average	 pHe	 values	 (±SD)	 for	 intratumoral	 and	
peritumoral	regions	in	untreated	and	TMZ	treated	U251	tumors	(C)	show	that	the	average	







(Figure	 5.4A).	 The	 boundaries	 between	 the	 intratumoral	 and	 the	 peritumoral	 regions	
(shown	with	white	and	black	arrows	for	the	treated	and	untreated	groups,	respectively,	in	
Figure	5.4B)	were	calculated	from	the	average	tumor	volume	obtained	from	the	anatomical	
MR	 images	 (Figure	 5.1B),	 assuming	 a	 spherical	 tumor	 shape.	 Lower	 pHe	 values	 were	
observed	in	the	intratumoral	regions	(ROIs	1	and	2)	in	the	untreated	group	(Figure	5.4B).	
In	 the	 treated	 group,	 the	 pHe	 values	 in	 the	 intratumoral	 regions	 (ROI	 1)	 were	 partially	










temozolomide	 effect	 on	 intratumoral	 pHe	 across	 different	 animals.	Note	 that	most	 of	 the	
intratumoral	 regions	 for	 the	 treated	 group	 is	 restricted	 to	 ROI	 1,	 based	 on	 the	 tumor	











distance	 from	the	corresponding	voxel	 to	 the	center	of	mass	of	 the	 tumor.	Each	ROI	was	
defined	as	the	area	bounded	by	two	circles	of	radius	n-1	mm	to	n	mm	from	the	center	of	mass	
of	the	tumor	(n=1	to	10).	The	average	pHe	value	for	each	animal	was	calculated	from	the	pHe	
values	 from	 all	 the	 voxels	 inside	 each	 ROI.	 Then,	 the	 average	 pHe	 values	 and	 the	
corresponding	 standard	 deviations	 (indicated	 as	 the	 error	 bar)	 across	 animals	 were	
calculated	for	each	ROI	(B).	The	boundaries	between	the	intratumoral	and	the	peritumoral	






All	U87	animals	 (n=8)	had	baseline	 imaging	performed	at	Day	10	after	 tumor	cell	
inoculation.	Sorafenib	(n=4)	or	DMSO	control	(n=4)	was	administered	starting	on	Day	11.	
However,	all	animals	did	not	complete	the	full	imaging	protocol	as	there	were	losses	during	





Tumor	 volume	 was	 measured	 by	 manually	 outlining	 tumor	 boundaries	 on	 T2-
weighted	 and	 contrast-enhanced	 T1-weighted	 MRI	 across	 multiple	 slices	 allowing	 for	
complete	coverage	over	the	entire	tumor	volume.	Representative	T2-weighted	images	are	
shown	 in	Figure	5.5A	before	and	at	multiple	 time	points	after	 therapy	 in	both	sorafenib	
treated	and	control	tumors.	Quantitative	tumor	volumes	were	similar	in	treated	and	control	
tumors	 at	 baseline	 (15.1±10.2	mm3	 vs.	 17.2±10.7	mm3).	 However,	 tumor	 volumes	were	
lower	in	treated	tumors	versus	controls	at	day	15	(35.0±20.8	mm3	vs.	78.9±66.7	mm3)	and	
day	19	(58.1±40.1	mm3	vs.	145.1±91.7	mm3).	Since	tumor	volume	was	variable	at	baseline	





Figure	5.5.	 Effect	of	 sorafenib	 treatment	on	U87	 tumor	volume	and	morphology.	 (A)	T2-
weighted	MRI	at	baseline	(Day	10),	4	days	after	start	of	sorafenib	therapy	or	DMSO	control	









Quantitative	 T1	 mapping	was	 performed	 before	 and	 after	 the	 administration	 of	 a	
gadolinium	contrast	agent	(Dotarem).	Representative	T1-weighted	images	and	quantitative	




or	 four	 days	 after	 treatment	 (2.49±0.09	 s	 vs.	 2.48±0.13	 s);	 however,	 the	 intrinsic	 T1	 did	
increase	as	the	tumor	grew	larger	in	both	groups	(Figure	5.6B).	After	administration	of	the	




(p=0.05)	 (Figure	 5.6C).	 Additionally,	 the	 post	 contrast	 T1	 values	 in	 sorafenib	 animals	
continued	to	increase	at	later	time	points,	reaching	1.55±0.17	s	at	eight	days	post-treatment	
and	2.02±0.04	s	at	fifteen	days	post-treatment;	however,	T1	values	for	DMSO	controls	are	not	







Figure	5.6.	 Sorafenib	reduces	 the	delivery	of	contrast	agents	 to	 the	 tumor	and	effects	T1	
relaxation.	 (A)	 Representative	 T1-weighted	 images	 (TR/TE:	 1000/10	 ms)	 are	 shown	 at	
baseline	 (Day	 10)	 and	 four	 days	 after	 sorafenib	 therapy	 or	 DMSO	 control	 (Day	 15).	
Additionally,	quantitative	T1	mapping	for	the	same	tumors	are	shown	before	(intrinsic)	and	
after	(contrast-enhanced)	administration	of	0.25	mmol/kg	of	a	gadolinium-based	contrast	
agent	(Dotarem).	 In	all	 images	the	brain	 is	outlined	in	white	and	the	tumor	is	outlined	in	






DCE-MRI	was	 used	 to	 study	 the	 vascularity	 of	 sorafenib	 treated	U87	 tumors.	 The	
dynamic	data	was	fit	to	a	two-compartment	exchange	model	that	allowed	for	four	vascular	
parameters	to	be	quantified	and	spatially	mapped	across	the	tumor	at	multiple	time	points	
(Figure	 5.7A).	 Due	 to	 the	 limited	 number	 of	 animals	 and	 the	 highly	 variable	 parameter	
values	between	tumors,	no	changes	were	found	to	reach	statistical	significance.		The	Ktrans	












similarly	 seen	 in	 vp	 (0.012±0.012	 vs.	 0.017±0.007)	 (Figure	 5.7E).	 However,	 at	 later	























surgical	 interventions	 to	 increase	 the	 circulating	 concentration	 of	 the	 contrast	 agent	
(TmDOTP5-)	 as	 was	 performed	 for	 the	 TMZ	 studies	 in	 U251	 tumors.	 However,	 using	





baseline	 (Day	 10)	 (6.53±0.04	 vs.	 6.53±0.08,	 respectively).	 However,	 at	 four	 days	 post-
treatment,	 the	 pHe	 in	 sorafenib	 treated	 tumors	 increased	 to	 6.77±0.05,	 while	 in	 DMSO	
control	 tumors	 the	pHe	 remained	unchanged	 (6.58±0.06)	 (Figure	5.8B).	 The	 statistically	
significant	 (p=0.01)	 increase	 in	 pHe	 represented	 a	 trend	 towards	 normalization	 of	 the	
intratumoral	pHe	as	normal	brain	pHe	is	~7.1-7.3.	Notably,	this	increase	in	pHe	began	within	














pHe	 for	 each	 time	 point	 across	 all	 tumors.	 All	 values	 are	 shown	 as	 average	 ±	 standard	








Assessment	 of	 therapeutic	 response	 in	 GBMs	 is	 usually	 achieved	 by	 T1-	 and	 T2-
dependent	MRI	contrasts.	However,	these	methods	can	be	confounded	by	pseudoprogresson	
and	pseudoresponse.	 Thus,	 alternative	methods	 for	monitoring	 therapeutic	 response	 are	
needed.		
Various	MRS	and	MRI	techniques	 for	pHe	mapping	have	been	previously	reported.	
Gallagher	 et	 al.	 imaged	 pHe	 in	 mouse	 lymphoma	 using	 hyperpolarized	 13C	 bicarbonate	
measurements.109	pHe-sensitive	contrast	was	measured	 in	C6	glioma	rats	using	GdDOTA-
4Amp5-,	 a	 pH	 sensitive	 T1	 agent.88	 MRI	methods	 based	 on	 chemical	 exchange	 saturation	
transfer	 (CEST),	 using	 either	 diamagnetic	 or	 paramagnetic	 agents	 have	 been	 used	 to	
generate	 pHe-sensitive	 maps	 such	 as	 CEST	 imaging	 of	 the	 amine	 protons	 on	 glutamine.	
Amide	proton	transfer	(APT)	and	amine	CEST	have	been	used	in	both	preclinical	and	clinical	
settings.130,197	
BIRDS	 is	 a	 different	 technique,	 which	 has	 been	 used	 to	 image	 the	 intratumoral-
peritumoral	 pHe	 gradient	 in	 gliomas.141,198	 Because	 the	 molecular	 readout	 from	 the	
TmDOTP5-	protons	is	chemical	shift-dependent,	the	method	is	independent	of	field	strength	





conventional	MRI,	 the	 pHe	 readout	 even	 at	 a	 course	 spatial	 resolution	 provides	 valuable	
insights	into	the	tumor	microenvironment	in	relation	to	its	neighboring	tissue.		
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	It	 was	 observed	 by	 Estrella	 et	 al.	 (2013)	 that	 regions	 of	 highest	 tumor	 invasion	
corresponded	to	regions	of	lowest	pHe.5	So,	it	is	hypothesized	that	acidic	pHe	mediates	local	
invasive	 growth	 and	 metastasis.	 Recently,	 we	 showed	 that	 extensive	 acidic	 pHe	 in	 the	
periphery	of	 the	 tumor	 is	 correlated	with	 increased	 invasiveness.	This	 is	 associated	with	
increased	 presence	 of	 Ki-67	 positive	 cells	 in	 the	 tumor	 boundary	 of	 invasive	models.141	
Similarly,	in	untreated	tumors	we	observed	lower	pHe	in	the	tumor	boundary	and	increased	
presence	of	Ki-67	positive	cells	 indicative	of	 increased	proliferation	and	 invasive	growth.	
TMZ	treatment	in	U87	rat	gliomas	has	shown	alterations	in	the	lactate	to	pyruvate	ratio	in	
comparison	 with	 untreated	 rats	 due	 to	 reduced	 pyruvate	 kinase	 M2	 activity.199,200	 In	
addition,	reduced	metabolic	output	in	response	to	reduced	tumor	burden	suggests	altered	
pHe	in	intratumoral	and	peritumoral	regions	in	response	to	TMZ.	We	observed	an	inhibition	
of	 tumor	 growth	 with	 TMZ	 treatment,	 similar	 to	 several	 previous	 reports.200-203	 Also	 in	
agreement	 with	 previous	 studies,	 we	 observed	 apoptosis	 induction	 and	 reduced	
proliferation	with	TMZ	treatment.199,203	
In	a	recent	report	by	Huang	et	al.,	we	present	an	alternative	method	for	achieving	a	
transient	 increase	 in	 the	circulatory	concentration	of	BIRDS	agents	 (TmDOTP5-)	by	using	
probenecid.135	Probenecid	is	an	organic	anion	transporter	inhibitor	that	is	used	to	decrease	
the	renal	excretion	rate	of	antibiotics	and	certain	other	drugs	and	thus	achieve	 increased	
drug	 concentration.	 Co-infusion	 of	 probenecid	 along	 with	 TmDOTP5-	 showed	 that	
intratumoral	 peritumoral	 pHe	 gradient	 was	 unaffected	 by	 co-infusion.	 This	 allowed	 for	
longitudinal	studies	to	be	performed	in	a	cohort	of	U87	tumors	treated	with	sorafenib.		
Here	we	demonstrate	longitudinal	pHe	mapping	with	BIRDS	for	the	first	time	in	the	
context	 of	 treatments	 (sorafenib).	 The	 pHe	 increased	 significantly	 after	 four	 days	 of	
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treatment	with	the	TKI	sorafenib.	This	suggests	that	although	the	morphologic	appearance	
of	 the	 tumor	 is	 unchanged,	 the	 vascular	 and	 metabolic	 features	 of	 the	 tumor	
microenvironment	are	 impacted	early	 in	 the	 treatment	course.	While	we	did	observe	 the	
reduction	 in	 contrast	 enhancement	 after	 administration	 of	 gadolinium	 contrast	 agents	
(Dotarem)	expected	with	sorafenib	therapy,	these	changes	were	very	modest	at	the	earliest	
time	points	after	 therapy.	Additionally,	DCE-MRI	 is	 frequently	used	 to	 study	 the	vascular	
features	 of	 the	 tumor	 microenvironment.	 However,	 in	 the	 setting	 of	 anti-angiogenic	






support	 for	 this	 finding	comes	 from	measures	of	 the	apparent	diffusion	coefficient	(ADC)	
that	has	been	correlated	with	tumor	cellularity,	such	that	reductions	in	ADC	represent	more	
highly	cellular	 tumors.80	However,	changes	 in	 tumor	ADC	 in	U87	tumors	 is	not	observed.	
Therefore,	the	reductions	in	pHe	early	during	the	course	of	therapy	can	represent	a	novel	
way	to	differentiate	a	therapeutic	response.		
In	 conclusion,	mapping	 pHe	 in	 intratumoral	 and	 peritumoral	 regions	 using	 BIRDS	
could	serve	as	a	biomarker	in	evaluating	therapeutic	response	in	gliomas	which	in	turn	could	






In	 the	 work	 presented	 in	 this	 dissertation,	 we	 have	 used	 a	 variety	 of	 magnetic	
resonance	 imaging	 (MRI)	and	spectroscopic	 imaging	 (MRSI)	methods	 to	 study	 the	 tumor	
microenvironment	in	human-derived	preclinical	models	of	glioblastoma.	In	particular,	we	
have	 further	developed	Biosensor	 Imaging	of	Redundant	Deviation	 in	Shifts	 (BIRDS)	as	a	
quantitative	tool	for	studying	tumor	metabolism	as	reflected	by	an	acidic	extracellular	pH	
(pHe).	 In	 prior	 work,	 BIRDS	 pHe	 mapping	 has	 been	 used	 to	 measure	 the	 intratumoral–
peritumoral	 pHe	 gradient	 in	 9L	 and	 RG2	 rodent	models	 of	 gliomas	 and	 to	 correlate	 the	
extensive	acidic	pHe	in	regions	surrounding	the	tumor	with	tumor	cell	invasion.141	Here,	we	
have	 expanded	 BIRDS	 to	 image	 the	 acidic	 pHe	 in	 several	 human-derived	 models	 of	
glioblastoma	(U87	and	U251).		
While	prior	work	using	BIRDS	has	 relied	on	 renal	 intervention	 to	 reduce	 contrast	
agent	clearance,	a	BIRDS	protocol	was	developed	using	pharmacologic	 inhibition	of	renal	






Further,	 the	 longitudinal	 BIRDS	 protocol	 allowed	 for	 measuring	 the	 acidic	
microenvironment	 throughout	 tumor	progression	 (Chapter	4).	We	 combined	BIRDS	with	
other	MRI	techniques,	including	diffusion-weighted	imaging	and	dynamic	contrast	enhanced	
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imaging	 to	 provide	 imaging	markers	 of	 tumor	 cellularity	 and	 vascularity,	 allowing	 for	 a	
thorough	 characterization	 of	 the	 vascular	 and	 metabolic	 features	 of	 the	 tumor	
microenvironment.	 We	 made	 simultaneous	 and	 longitudinal	 measurements	 of	 tumor	
perfusion	(Fp),	permeability	(Ktrans),	and	volume	fractions	of	interstitial	(ve)	and	plasma	(vp)	
spaces	 from	 dynamic	 contrast	 enhanced	 (DCE)	 MRI,	 cellularity	 from	 apparent	 diffusion	
coefficient	(ADC)	MRI,	and	extracellular	pH	(pHe)	from	BIRDS.	Spatiotemporal	patterns	of	
these	parameters	during	tumorigenesis	were	unique	for	each	tumor	and	both	U251	and	U87	
tumors	 became	 acidic	 (pHe	 6.1-6.8)	 early	 during	 tumor	 formation	 and	 remained	 acidic	
throughout	tumor	progression.	While	there	was	no	correlation	between	tumor	size	and	pHe,	
U251	tumors	were	more	acidic,	suggesting	lower	aerobic	glycolysis	than	in	U87	tumors.	
Finally,	 we	 provided	 further	 evidence	 supporting	 the	 role	 of	 pHe	 as	 a	 potential	
biomarker	 of	 therapeutic	 response	 (Chapter	 5).	 Rats	 bearing	 U251	 gliomas	 treated	with	
temozolomide	 (40	 mg/kg)	 had	 a	 lower	 intratumoral–peritumoral	 pHe	 gradient	 and	 a	
reduced	 tumor	 volume	 with	 increased	 proliferation	 and	 induction	 of	 apoptosis	 when	
compared	 to	 untreated	 rats.142	 Additionally,	 rats	 bearing	 U87	 gliomas	 had	 an	 increased	
intratumoral	pHe	with	sorafenib	(100	mg/kg)	therapy.	BIRDS	was	shown	to	be	able	to	be	
used	 to	 map	 the	 pHe	 in	 gliomas	 and	 provide	 a	 physiological	 readout	 of	 the	 therapeutic	
response	on	the	tumor	microenvironment.	
Using	imaging	methods	sensitive	to	the	cellular,	vascular	and	metabolic	features	of	










of	 glioblastoma,	 we	 sought	 to	 gain	 further	 insight	 into	 the	 role	 of	 central	 necrosis	 and	










high	propensity	 to	 spread	 to	 the	brain.205	Brain	metastases,	particularly	 from	melanoma,	
present	a	challenge	in	diagnosis	and	therapeutic	monitoring.	The	presentation	of	metastatic	
disease	 is	 highly	 heterogeneous	based	on	 location	 and	number	 of	 tumors,	 as	well	 as	 the	
tissue	in	which	it	grows	being	different	from	the	tissue	from	which	the	tumor	was	derived.		
Recent	 therapeutic	 advances	 have	 made	 significant	 progress	 in	 the	 treatment	 of	
metastatic	melanoma	 to	 the	 brain	 using	 surgery,	 radiation,	 and	 novel	 immunotherapies,	





and	 immune	 secreted	 factors.	 Edema	 can	 provide	 a	 route	 for	 tumor	 spread	 and	 impacts	
therapeutic	efficacy,	with	edema	being	a	contradiction	to	immune	therapies.207	Additionally,	
an	 acidic	 pHe	 has	 also	 been	 associated	 with	 increased	 migration	 and	 invasion	 in	
melanoma.123,208,209	However,	there	are	limited	preclinical	models	available	to	reliably	study	
this.		




cells,	 either	 directly	 or	 after	 short	 term	 cell	 culture,	 into	 immunosuppressed	 rodents.	 In	
particular	for	imaging	characterization,	no	PDX	model	of	metastatic	melanoma	in	rats	has	
been	 reported	 previously.	 It	 has	 been	 shown	 that	 acidosis	 develops	 in	 melanoma;210	
however,	the	effect	of	maintaining	an	acidic	extracellular	pH	(pHe)	and	how	it	contributes	to	
tumor	 invasiveness,	 proliferation,	 and	 inhibited	 therapeutic	 response	 in	 patient-derived	














grow	and	checked	every	7	days	 for	 luminescence	with	an	 in	vivo	 imaging	system	(Perkin	
Elmer)	after	intravenous	administration	of	luciferin	(150	mg/kg).	Once	tumors	reached	their	
growth	endpoint,	 the	MRI/MRS	protocol	 for	quantitative	relaxation	(T1,	T2)	and	diffusion	














A	 benefit	 of	 using	 labeled	 cells	 was	 that	 tumor	 growth	 could	 be	 tracked	 using	
luminescence	imaging,	rather	than	MRI	(Figure	6.2).	The	level	of	luminescence,	while	not	
perfect,	 is	reflective	of	the	size	of	the	tumor.	Once	significant	levels	of	luminescence	were	
present,	 the	 tumor	was	 then	 imaged	 using	MRI.	 As	with	 other	 tumor	models,	 there	was	






















melanoma.	 Imaging	 was	 performed	 using	 an	 in	 vivo	 imaging	 system	 after	 intravenous	
administration	of	luciferin.	All	images	are	acquired	from	the	same	animal	at	different	time	






Figure	6.3.	 Comparison	 of	A375BR	 and	YUMETRO	PDX	models	 of	metastatic	melanoma.	
Anatomical	 T2-weighted	 MRI	 is	 shown	 along	 with	 corresponding	 quantitative	 T2	 maps.	







The	YUMETRO	PDX	model	was	compared	against	 the	A375BR	cell	 line,	which	 is	 a	
commercially	 available	melanoma	model	 (Figure	6.3).	MRI	 and	MRSI	was	performed	on	
both	 cell	 lines	 at	 11.7T.	 A375BR	 tumors	were	much	more	 homogenous	 in	 their	 growth,	
lacked	 peritumoral	 edema,	 and	 grew	 to	 much	 larger	 sizes	 at	 earlier	 times	 points	 in	
comparison	 to	 YUMETRO	 tumors.	 Both	 A375BR	 and	 YUMETRO	 tumors	 were	 acidic	 as	
measured	by	BIRDS	with	pHe	values	of	6.3-6.7,	although	A375BR	was	slightly	more	acidic	
indicating	higher	rates	of	glycolytic	metabolism.	Regions	of	peritumoral	edema	in	YUMETRO	
tumors	 exhibited	higher	T2	 and	ADC	values;	 however,	 no	 edema	was	 evident	 in	A375BR	
tumors.	 Finally,	 intratumoral	 regions	 of	 increased	 T2	 and	 ADC	 developed	 in	 YUMETRO	
tumors	that	were	not	evident	in	A375BR	and	may	represent	regions	of	necrosis.	
	 PDX	models	of	metastatic	melanoma	in	rats	provide	a	new	platform	for	evaluating	the	
development	 of	 acidosis	 in	 tumors.	 This	 preliminary	 work	 highlights	 the	 differences	 in	














a	 large	 animal	model	 is	 desirable.	 The	 VX2	 tumor	model	 is	 an	 orthotopic	 liver	 tumor	 in	
rabbits	 that	 exhibits	 growth	 patterns	 characteristic	 of	 hepatocellular	 carcinoma	 and	 has	
been	 previously	 used	 for	 translational	 studies	 involving	 intra-arterial	 therapies	 for	 liver	
cancer	 treatment.213,214	 To	 demonstrate	 the	 feasibility	 of	 BIRDS	 on	 a	 lower-field	 clinical	



























tumors	 (red	 contour)	were	 localized	 as	 a	 hypointensity	 in	 the	 T1-weighted	 VIBE	 images	
(Figure	 6.4A)	 within	 the	 whole	 liver	 (blue	 contour)	 and	 the	 rabbit	 abdomen	 (orange	























(6.89±0.09),	 compared	 to	 those	 for	 the	 normal	 liver	 (7.22±0.04).	 Reproduced	 with	
permission.181	
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values	 were	 used	 to	 display	 the	 voxel	 fractions	 corresponding	 to	 each	 pHe	 range	 (A).	
Intratumoral	 regions	 of	 VX2	 tumors	 (red),	 the	 tumor	margin	 (orange)	 and	 normal	 liver	












the	 tumor,	due	 to	excellent	blood	perfusion	 in	 the	 liver.	The	 linewidths	of	 the	TmDOTP5-	










suggesting	 that	 acidosis	 may	 spread	 into	 surrounding	 tissue.	 A	 similar	 result	 has	 been	

















by	 central	 necrosis	 and	 peritumoral	 edema.	 Necrosis	 forms	 where	 regions	 of	 	 hypoxia	
develop,	leading	to	tumor	cell	migration	and	a	pseudopalisading	pattern.225	In	vitro	work	has	
shown	that	necrotic	cells	can	promote	tumor	infiltration.226	Further,	the	presence	of	edema	
is	 associated	with	 a	 poor	 clinical	 outcome.227	 The	presence	 of	 edema	 involves	 additional	
clinical	management	with	corticosteroids	(such	as	dexamethasone)	that	also	may	contribute	
to	worse	outcomes.	There	has	been	increased	interest	in	understanding	the	role	of	edema	in	





a	 variety	 of	 different	 immunotherapy	 strategies	 have	 been	 attempted.228	 However,	 the	
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microenvironment	 is	 immunosuppressive	 which	 limits	 the	 ability	 of	 standard	 anti-
programmed	 cell	 death	 protein-1	 (anti-PD1)	 immunotherapy.	 Recent	 evidence	 suggests	




opportunity	 to	 study	 these	 patterns	 in	 glioblastoma.	 Volumetric	 analysis	 using	 MRI	 has	
shown	 hyperintensity	 on	 T2-weighted	 FLAIR	 images	 in	 the	 peritumoral	 region	
corresponding	to	edema,	as	well	as	a	contrast	enhancing	rim	surrounding	a	non-contrast	
enhancing	 core	 corresponding	 with	 necrosis.231,232	 Although	 edema	 can	 be	 identified	 on	
standard	 T2-weighted	 MRI,	 edema	 can	 also	 be	 detected	 as	 an	 increase	 in	 the	 apparent	








tumor	 growth.	 Imaging	 data	 were	 acquired	 using	 an	 11.7	 T	 Bruker	 horizontal-bore	
spectrometer.	All	imaging	was	performed	once	the	animals	reached	their	terminal	endpoint	
so	 that	 histological	 comparisons	 could	 be	 made	 with	 corresponding	 MRI.	 The	 imaging	




experiment,	 animals	 were	 perfused	 and	 the	 brain	 was	 extracted	 and	 fixed	 in	 4%	
paraformaldehyde	 prior	 to	 slicing	 into	 3	 mm	 coronal	 slabs.	 The	 tissue	 was	 paraffin	
embedded	 and	 sectioned	 into	 10	 µm	 slices.	 Tissue	 sections	 underwent	
immunohistochemistry	 (IHC)	 for	 proliferating	 cell	 nuclear	 antigen	 (PCNA)	 and	 cluster	 of	
differentiation	 68	 (CD68)	 with	 hematoxylin	 as	 a	 counterstain.	 In	 brief,	 sections	 were	
deparaffinized	and	rehydrated	prior	to	antigen	retrieval	and	peroxidase	blocking.	Sections	
were	 incubated	 with	 primary	 antibodies	 (PCNA,	 CD68)	 followed	 by	 incubation	 with	 a	
biotinylated	secondary	antibody	and	3,3-diaminobenzidine	(DAB).	All	stained	sections	were	
mounted	 on	 glass	 slides	 and	 microscopy	 was	 performed	 (4x,	 10x)	 for	 digitization	 and	










intratumoral	 region	 as	 well	 as	 regions	 of	 necrosis,	 peritumoral	 edema	 and	 a	 contrast-
enhancing	 rim	 (Figure	 6.6).	 Contrast	 agent	 accumulation	 and	 clearance	 is	 evident	 in	
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is	 more	 pronounced	 in	 U251	 tumors	 with	 a	 slower	 dynamic	 uptake	 of	 contrast	 agent	
compared	to	intratumoral	regions.	Edematous	regions	are	initially	non-contrast	enhancing	
and	are	much	more	pronounced	in	U251	tumors;	however,	at	later	times	during	the	dynamic	
acquisition,	 edematous	 regions	 did	 exhibit	 slight	 increases	 in	 signal	 that	 may	 allow	
differentiation	 of	 edematous	 regions	 from	normal	 appearing	 brain.	 Based	 on	 patterns	 of	
contrast	uptake,	these	tumor	regions	can	be	uniquely	identified	with	contrast-enhanced	T1-




Figure	6.6.	Region	of	 interest	 (ROI)	analysis	 for	U87	and	U251	 tumors.	T2-weighted	and	
contrast-enhanced	T1-weighted	imaging	are	shown	for	U87	(A)	and	U251	(B)	tumors.	ROIs	
were	defined	for	the	intratumoral	region	(green),	contrast	enhancing	rim	(yellow),	necrosis	
(red),	 edema	 (light	 blue)	 and	 contralateral	 hemisphere	 (dark	 blue).	 Dynamic	 signal	
enhancement	 during	 contrast	 agent	 administration	 from	 DCE-MRI	 are	 shown	 for	 each	




To	 further	 evaluate	 the	 changes	 occurring	 in	 regions	 of	 peritumoral	 edema,	
















Figure	6.7.	MRI	 and	 immunohistochemical	 evaluation	 of	 peritumoral	 edema	 in	U87	 and	
U251	tumors.	T2-weighted	and	contrast-enhanced	(CE)	T1-weighted	imaging	for	U87	(top	
row)	and	U251	(bottom	row)	tumors	are	used	to	highlight	peritumoral	edema	and	central	







The	 tumor	 microenvironment	 in	 glioblastoma	 is	 unique	 due	 to	 the	 distinctive	
features	of	brain	tissue	in	which	these	tumors	form.	This	environment	creates	a	favorable	
space	 for	 tumor	 cells	 to	 survive	 and	 thrive.	 Further,	 the	 environment	 is	 adaptable	 with	
immature	 and	 permeable	 vasculature	 and	 significant	 acidosis	 that	 develops	 early	 during	
tumor	 progression	 and	 promotes	 tumor	 infiltration	 into	 surrounding	 tissue.	 Given	 these	
changes,	 there	 is	 significant	 benefit	 to	 developing	 imaging	 methods	 that	 allow	 for	






leading	 to	 the	 phenomenon	 of	 pseudoprogression	 and	 pseudoresponse.	 Further,	
glioblastoma	 is	 difficult	 to	 biopsy	 and	 while	 tumor	 tissue	 is	 available	 at	 time	 of	 tumor	
resection	 for	molecular	 analysis,	multiple	 surgeries	or	 subsequent	biopsy	are	not	 always	
performed.	 Advanced	 MRI/MRS	 methods	 could	 be	 added	 to	 already	 existing	 imaging	








The	 goal	 of	 this	 work	 was	 to	 demonstrate	 methods	 available	 for	 quantifying	
metabolic	 and	 vascular	 features	 of	 the	 tumor	 microenvironment	 to	 complement	 the	
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